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EXECUTIVE SUMMARY 
 
The population growth and tendency to a healthier lifestyle increase the demand to the 
investigation of additional human needs for food and natural products. At the same 
time, the will to decrease and replace compounds from synthetic sources has led to 
the emergence for new natural substances to be used as food additives, as ingredients 
in drugs and nutraceuticals, or in cosmetics. Under these circumstances, microalgae 
and bioactive compounds from microalgae compose with any doubt an incredible 
solution pursuant to their high added value in new industrial applications. 
 
Algae are able to manufacture different kinds of biologically active metabolites such 
as, vitamins, carotenoids, proteins, lipids, PUFAs, pigments, polysaccharides and 
phenolic compounds. Among them compounds, carotenoids are generally reported 
with considerable interest at the recent years. Specifically, astaxanthin is a bioactive 
compound with high nutritional value possessing strong demand as well as important 
market share. The current market is mainly dominated by the chemical synthesis of 
astaxanthin due to the high cost of the cultivation, production and harvesting of the 
natural counter pack, which is reached of 2.200-6.220 €/kg. 
 
Thus, the overall mission of this study constitutes the change in the ordinary cultivation 
methods of microalgae with utilizing a new magnetic nanotechnology to cultivate them. 
The goal of this research is to reduce the cost of astaxanthin production up to 
competitive levels with those of synthetic one. This study outputs will bring to the 
market an economically, environmentally and socially new procedure at the production 
of astaxanthin as a raw material and finally the exploitation of this bioactive compound 
in a broad variety of industrial applications with remarkable outcomes. 
 
 
 
 
 
 
Key words: microalgae, bioactive compounds from algae, carotenoids, astaxanthin, 
astaxanthin from H. pluvialis, magnetic photobioreactor 
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OBJECTIVE 
 
In the case of large scale astaxanthin production, this pigment seems to have been 
high economic growth potential in the market. The main disadvantage of natural 
astaxanthin is that the production and exploitation of this bioactive compound is 
required high costs for infrastructure of culture systems as well as additional methods 
of processing. The purpose of this study is to provide the reader a new magnetic 
cultivation and production system of algae and more specifically astaxanthin from H. 
pluvialis with a cost-effective way. The current research gives information on common 
cultivations systems as compared to the novel magnetic system, the industrial 
applications of this pigment, the expected market at the emerging period and the 
competition worldwide. Furthermore, an economic performance during the production 
process of microalgae for the scaling up of astaxanthin with the suggested system 
constitute the core of this Master Thesis.  
 
All this information is useful for the reader to understand the idea of Valuemag project 
and the scope which it was developed, with the final aim of presenting the competitive 
advantage of the natural astaxanthin for a wide range industrial application and its 
superiority to competing products. 
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1. THE CONCEPT 
1.1 Introductory 
During the latest years, consumers have been pulling more and more notice to 
environmental and sustainability issues with the same focus as to life-style matters and 
their impact on their health. There is a great concern about the origin and safety of 
products, likewise, manufacturing processes with the environmental consequences.  
Regarding these concerns, there is a need for investigation of natural products with a 
great variety of functions, as well as food, nutraceuticals and cosmetics. Also, due to 
the safety of natural sources, consumers orient towards them as compared with 
synthetic ones (Pimentel et al., 2018). As a result of this can be strong encouragement 
for the industrial world to examine new opportunities in novel/ alternative natural raw 
materials with extra attributes and functions that go further than their ordinary 
applications (e.g., nutrition) (Harnedy and FitzGerald, 2011); (Bixler and Porse, 2011); 
(Pimentel et al., 2018). 
Accomplishing a good enough nutrition may be a growing international concern with 
the rise in world population. Consequently, cost‐effective sources of nutrients which 
will easy and speedily manufacture large quantities of products of high nutritional value 
is required. Algae can be a significant source of a various number of strictly necessary 
nutrients to support human health (García et al., 2017). 
1.2 Microalgae 
In the past few years, microalgae have attracted increasing attention for manufacturing 
a wide range of “high value-added compounds”, that are helpful in many aspects of 
our life. Bibliography data demonstrate that microalgae are made up of molecules 
which will be utilized in several industrial sectors like pharmaceutics, nutraceuticals, 
food additives and natural cosmetics (Gordon and Juergen, 2007); (Leu et al., 2014); 
(Molino et al., 2018); (Wang et al., 2015); (Wang et al., 2017). The commercial 
applications at these markets are characterised by high-quality safe products at 
competitive prices. Within this context, microalgae represent the starting point to 
produce natural compounds with a sustainable method with low environmental impact 
(Pulz and Gross, 2004); (Spolaore et al., 2006). 
Marine algae, additionally known as seaweed, are photosynthetic eukaryotic 
organisms that may be found in fresh water and marine environment with tenacious 
vitality (Wang et al., 2017). Grow in a variety of aquatic habitats, as well as lakes, 
pounds, rivers, oceans, and even wastewater (Barsanti et al., 2008). Algae are 
generally classified by size as macroalgae or microalgae and in line with their 
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morphological pigmentations as Rhodophyta (red algae), Phaeophyta (brown 
algae) and Chlorophyta (green algae) (Khan et al., 2018). 
1.3 Bioactive Compounds from microalgae and applications 
Microalgae can adapt rapidly in harsh/extreme environmental conditions, tolerating a 
wide range of conditions (e.g., variable salinity, temperature, nutrients, UV–irradiation) 
due to a completely different adaptation strategy. Therefore, they will produce a great 
variety of fascinating secondary metabolites (having putative biological activities) with 
novel structures and potential to survive in such various diverse and extreme 
environments, that are typically not found in other organisms. Since microalgae are 
one among the most commonly studied and used marine resources, bioactivities of 
the constituent of marine algae have been widely investigated (Mobin and Alan, 2017); 
(Wang et al., 2017). 
Microalgae have a major ability to convert atmospheric CO2 to useful bioproducts, as 
well as polysaccharides, lipids, pigments, proteins, vitamins, bioactive 
compounds and antioxidants (Figure 1) (Khan et al., 2018). 
Figure 1: Microalgae convert atmospheric CO2 to valuable bioproducts (vitamins, lipids, carbohydrates 
and others) by using light. Microalgae biomass is a rich source for biofuels and bioactive compounds 
(Brennan and Owende, 2010). 
Microalgae can be a rich source of carbon compounds which may be utilised in a wide 
range of industrial applications (Das et al, 2011). Its application for biofuel production 
and wastewater purification have been extensively reported (Mobin and Alan, 2014); 
(Mobin and Alan, 2018). Microalgae may be used for other industrial applications like 
high-value food and pharmaceutical products, nutraceuticals (nutritional 
ingredients), health food for human, food and fodder additives, polysaccharides, 
cosmeceuticals, bioremediation, antioxidant, dyes, food for cultivation or 
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bioplastic production, wastewater treatment and atmospheric CO2 mitigation 
(Mobin and Alan, 2017). 
1.4 Microalgae species 
Microalgae have over 300,000 species out of that around 30,000 are reported (Mobin 
and Alan, 2017). In line with their classification, each group contains many species and 
each of these species have thousands of strains. Only a little number of these 
selections have been explored for potential beneficial use. Table 1 highlights some 
major microalgal species/groups, their products and biotechnological applications 
(Mobin and Alan, 2017). 
Table 1: Some major microalgal species, products and areas of application (Mobin and Alan, 2017).  
 
Species/group Product Areas of application 
Arthrospira (Spirulina) platensis Phycocyanin, biomass Health food, cosmetics 
Arthrospira (Spirulina) Protein, Vitamin B12 Antioxidant capsule, immune system 
Aphanizomenon flos-aquae Protein, essential fatty acids, β-carotene Health food, food supplement 
Chlorella spp. Biomass, Carbohydrate extract Animal nutrition, health drinks, food 
supplement 
Chlorella vulgaris Biomass, Carbohydrate extract Health food, food supplement, feeds 
Dunalienna salina Carotenoids, β-carotene Health food, food supplement, feeds 
Haematococcus pluvialis Carotenoids, astaxanthin Health food, pharmaceuticals, feeds 
Odontella aurita Fatty acids, EPA Pharmaceuticals, cosmetics, anti-
inflammatory 
Porphyridium cruentum Polysaccharides Pharmaceuticals, cosmetics 
Isochrysis galbana Fatty acids Animal nutrition 
Phaedactyhon tricomutum Lipids, fatty acids Nutrition, fuel production 
Lyngbya majuscule Immune modulators Pharmaceuticals, nutrition 
Scennedesmas spp. Protein Aquaculture, human nutrition 
Schizochytrium sp. DHA and EPA Food, beverage and supplement 
Crypthecodinium cohnii DHA Brain development, Infant health and 
nutrition 
Nannochloropsis oculata Biomass Food for larval and juvenile marine Fish 
Nannochloropsis sp EPA Food supplement and pharmaceuticals 
 
1.5 Currently applications of microalgae and new opportunities 
Many species of microalgae are used as source of wealthy nutrient food, feed, and 
health promoting compounds (Shah et al., 2016). Presently, microalgae products are 
available both in pure form as extracts, tablets, or capsules and as additives to a few 
food products which are either used as nutrients or food colouring agents with high 
nutritional value (Khan et al., 2018).  
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Among the commercially vital compound of microalgae, carotenoids have been 
presented attractive in industrial world with astaxanthin to play the leading role in 
recent years. Astaxanthin from Heamatococcus pluvialis is the richest source of 
natural astaxanthin that is regarded as “super anti-oxidant” with considerably greater 
antioxidant capability than the synthetic one, as we will explain at the following sector 
(Shah et al., 2016). Astaxanthin has vital applications and are extremely promising for 
potential uses within the nutraceuticals, cosmetics, food, and aquaculture industries 
(Shah et al., 2016). Astaxanthin will fairly reduce free radicals and oxidative stress and 
facilitate human body maintains a healthy state (Shah et al., 2016). With significant 
productiveness and increase in demand, astaxanthin is one among the high-value 
microalgal products in the future (Panis et al., 2016); (Shah et al., 2016). 
1.6 Limitations 
Even though microalgae are possible for uses like as biofuel sources and 
biopharmaceuticals generally, some limitations and challenges remain, that should be 
overcome to improve the technology from pilot-phase to industrial level. The foremost 
challenging and major issues are: 
- enhancing microalgae growth rate and synthesis of final products  
- dewatering algae culture for biomass production (filtration, centrifugation)  
- pre-treating biomass 
- isolation and purification of bioactive compounds (e.g. rate of recovery, purity, 
content) 
- and finally optimizing manufacturing process in all stages (Khan et al., 2018). 
Moreover, costs of infrastructure, cultivation and harvesting are the most crucial 
matters at the production of astaxanthin. To make astaxanthin extraction from H. 
pluvialis additional competitive than synthetic one and, at the same time, promote its 
use within the same markets. Consequently, it's necessary to overcome important 
points associated with the biomass concentration, treatment and degradation reactions 
that may provide each quality and quantity of the extracted astaxanthin (Mercer and 
Armenta, 2011). 
1.7 Microalgae cultivation systems 
The commercial cultivation of microalgae has begun five decades ago (Mobin and 
Alan, 2017). Algae to grow and multiply, it only needs the support of sunlight and of 
basic components such as CO2 and water for the conventional plant photosynthesis to 
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convert solar energy into chemical energy through CO2 fixation (Adeniyi et al., 2018). 
There is a great variety of microalgae cultivation systems that can be placed outdoors 
or indoors. Cultivation systems range from open shallow raceway ponds to closed 
photobioreactors, as illustrated in Figure 2 (Enzing et al., 2014).   
1. Open Systems/ Natural Cultivation 
Natural cultivation methods include pond, lakes, and lagoon, which are classified 
based on natural water bodies e.g. shallow ponds, circular ponds and raceway ponds, 
Fig. 2(A). 
2. Closed Systems/ Artificial Cultivation 
Artificial cultivation methods are majorly photobioreactors which come in different 
shapes such as flat plate, tubular, and column, Fig. 2(B), (C) and (D) respectively. 
3. Indoor Production Systems  
Small scale for research and heterotrophic production systems (Enzing et al., 2014). 
 
Figure 2: Algae cultivation methods (A) natural cultivation method, (B) artificial cultivation method (flat 
plate photobioreactor), (C) artificial cultivation method (tubular photobioreactor), (D) artificial cultivation 
method (column photobioreactor) (Adeniyi et al., 2018). 
1.8 Comparison of the different cultivation systems 
Natural cultivation systems are normally cheaper to construct and operate, but the 
ponds make use of more energy to homogenize the nutrients. However, this cultivation 
system is more susceptive to environmental conditions such as variability in water, 
temperature, lighting, and evaporation. On the other hand, artificial cultivation system 
provides better controls overgrowth parameters and culture conditions, safe and 
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protected environment against predators, reduced CO2 losses and higher volumetric 
productivity (Adeniyi et al., 2018). 
All the limitations and challenges affecting the natural cultivation methods have been 
eliminated in artificial cultivation system is known as photobioreactors, but the 
development of more economical and efficient closed culturing systems is needed 
(García et al., 2017). As a result, the economic feasibility is still questionable due to 
the high operating cost (Adeniyi et al., 2018). 
The future challenge of microalgal biotechnology is determined by the improvement of 
large‐scale photobioreactors (PBRs) capable of operating under defined optimal 
conditions with minimal or without contamination risks (Wang et al., 2012). Also, 
escalate methodologies need to be improved for managing efficient light provisions, 
minimum CO2 losses, and effective mixing and reuse of generated oxygen (Gupta et 
al., 2015). 
1.9 New magnetic cultivation and extraction techniques 
According to all previous challenges, the team of the project VALUEMAG (Valuable 
Products from Algae Using New Magnetic Cultivation and Extraction Techniques) try 
to obtain a revolutionary solution for microalgae cultivation, harvesting and exploitation 
of biomass in order to manufacture and purify high-value biomolecules in an affordable 
and environmentally-friendly way. More specifically to arrive this complicated aim, 
VALUEMAG, as the main scope, develops an advanced magnetic method for 
micro-algae cultivation (https://www.valuemag.eu/). Moreover, the exploitation of 
algae and other aquatic biomass is in focus targeting the production of molecules 
for pharma, nutraceuticals, food additives and cosmetic applications 
(https://www.valuemag.eu/).  
Figure 3: The concept of VALUEMAG project, Schematic representation mPBRs (magnetic 
PhotoBioReactor) section (https://www.valuemag.eu/). 
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VALUEMAG will symbolized an integrated complicated system which will involve the 
transformation of microalgae by introducing Super Paramagnetic Ions (SPANs) and 
their immobilization in SOMAC (Soft Magnetic Cone) surface in a very closed-
controlled system (https://www.valuemag.eu/). This can permit fast microalgae 
biomass production at an affordable cost. Additionally, SPAN based-methodology can 
make purification step easy, economic and accurate (https://www.valuemag.eu/). At 
the identical time, wastewater recycling and CO2 capturing systems are performed to 
gain on the environmental benefits that microalgae-based processes and procedures 
provide (https://www.valuemag.eu/). In brief, 
✓ an innovative methodology is implemented based on the utilization of magnetic 
nanoparticles and a soft magnetic steel cone to cultivate algae and to purify the 
high-value products resulting from their metabolism  
✓ the advanced and revolutionary technology has been already tested at the 
small scale providing promising results  
✓ the project is completely self-sustaining, eco-friendly and can offer socio-
economic benefits for the individuals  
✓ the project addresses the dramatic reduction of microalgae production costs, 
permitting this technology to become a competitive durable alternative within 
the current market (https://www.valuemag.eu/). 
1.10 Objective and scope of the present investigation 
The innovation of this project is to produce high added value products with a cost-
effective way and enter to the current market with an economic & competitive 
innovative technology, environmentally friendly approach, socio-economic and 
development driving force. After having conducted research for some bioactive 
compounds extracted from algae, we selected astaxanthin since it is a compound with 
high nutritional value existing strong demand as well as important market share. The 
result of this project is the production of astaxanthin as a pilot extractant and finally the 
exploitation of this bioproduct for a wide range of industrial/commercial applications. 
Thus, the overall mission is the change of the cultivation method of microalgae 
compared with open and closed systems to a new technology which will dramatically 
reduce the cost of micro-algae cultivation (from 5-12€/kg to <0,3 €/kg of algae) and 
thus the astaxanthin production cost from harvested micro-algae.  
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2. THE TEAM 
2.1 Participants 
VALUEMAG is the result of the collaboration of 11 members from 9 European 
countries who provide all the necessary background and expertise to achieve the 
objectives of the project. The VALUEMAG Project combines primary production and 
processing industries, consumer brands, SMEs, research and technology centers and 
universities (https://www.valuemag.eu/). More specifically:  
❖ Leading research organizations with extensive experience in the continuous 
development of next generation technologies that combine top class academic 
know-how with a long tradition in providing solutions to major European 
industries (SUN, NTUA, ENEA, IPSAS)  
❖ Market-oriented industrial actors with international experience in the 
implementation of very large projects and the launching of new products and 
services (PNO, VTG) and  
❖ Highly specialized high-tech SMEs (NOMASICO, ECODUNA, THERACELL, 
IRIS, EXERGY). At Table 2, (Appendix A) are given the participants of the 
program. 
 
THERACELL is part of Qualia group of companies and provides its know-how in 
the commercialization process of those high-added value products with a history 
in cosmetics, nutraceuticals and hygienic food. THERACELL is an active SME in 
developing new pharmaceutical products and is particularly interested and skilled 
in treating nanoparticles to be inserted in various types of cells, including stem 
cells. This way, QUALIA will lead the task in industrialization of the raw material 
of astaxanthin and other high-added bioactive compounds from micro-algae in 
cosmetics and nutraceuticals. 
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3. THE PRODUCT 
3.1 Generally - Valuable compounds extracted from microalgae 
Marine life is incredibly rich in manufacturing numerous and unique chemical 
components, each primary and complex. Because of the tough conditions like high 
salinity, lack of nutrients, light and space, that make the marine surroundings 
competitive, organisms adjust to the environment by manufacturing numerous 
substances and metabolites, a lot of specific secondary metabolites produced by algae 
(macro and microalgae), that permit them to maintain their survival and defend 
themselves against external intimidations. Therefore, sea biodiversity presents the 
chance to investigate these molecules and realize novel and natural bioactive 
compounds (Pimentel et al., 2018). 
Microalgae are extraordinarily prominent producers of the many high-value natural 
compounds therefore as a result, algae produce a wide vary of important and valuable 
products for business purposes. The products which will be produced from microalgae 
are very plentiful and various (Table 3, Appendix A) and have been suggested with 
large range of functions for health effects, as illustrated (Table 4, Appendix A). They 
manufacture vitamins, that promote their importance as a nutritional food for people 
and animals. They produce differing kinds of medicinally necessary polysaccharides. 
Numerous species manufacture bioactive and commercially vital pigments, 
carotenoids synthesized by plants, algae and bacteria that play completely different 
physiological purposes and since of that they provide huge nutraceutical values. These 
pigments are crucial in therapies for tumorigenesis, neuronal disturbance, and visual 
diseases. Also, proteins can be extracted from microalgae with rich content such as 
phycobiliproteins from cyanobacteria and a few red algae. PUFAs (polyunsaturated 
fatty acids) are currently principally derived from fish oil however because of several 
concerns (e.g. exploitation of marine reserves in a high level, accumulation of toxic 
compounds in marine life, peculiar smell, unpleasant sense and flavour, oxidative 
instability), there's an increasing interest in exploitation microalgae by other source of 
PUFAs. Several microalgae are producers of various exopolysaccharides (EPS) that 
are widely known like thickeners and gelling additives with implementation in the food 
industry. Sterols will be acquired from microalgae, an alternative bioactive compound 
with interest. In addition, many microalgae contain phenolic compounds in high content 
that are the same as or maybe more than several common food sources. Finally, 
microalgae have been presented to be a supply of volatile compounds with 
antimicrobial activity (Khan et al., 2018); (Islam et al., 2017); (García et al., 2017); 
(Shah et al., 2016). 
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Most of the substances which extracted by microalgae have therapeutic effects (Khan 
et al., 2018). A few of them described below:  
✓ Anti-diabetic properties 
✓ Antioxidant activity 
✓ Anti-inflammatory activity 
✓ Anti-microbial activity 
✓ Anti-viral activity 
✓ Antitumoral activity 
 
After research of all these bioactive compounds from microalgae, we observed that 
astaxanthin from microalgae to be presented noticeable interest since it is a pigment 
including potential benefit, global market new entries/opportunities and incorporation 
of astaxanthin production into biorefining (Shah et al., 2016) with the new suggested 
magnetic cultivation system and extraction techniques. Moreover, this bio compound 
is incriminated for a variety of biological activities in human health with strong 
evidences, as we will see below §3.4, 3.7. As a result, astaxanthin has a wide range 
of commercial importance providing strong role in food, feed/aquaculture, cosmetics 
and biopharma. 
This study focuses on reviewing interesting biochemicals from algae biomass with 
leading role in the carotenoids. More specifically our product is the astaxanthin, as a 
raw material from natural sources (Haematococcus pluvialis), that cultivated with 
a new magnetic cultivation system and extracted with the highest feasible content 
combining the Valuemag technology. So that concept bringing it very close to the 
market, with environmentally (water cleaning and CO2 capturing) and socially 
(inexpensive production) sustainable issues involved at the production of natural 
astaxanthin. 
3.2 Carotenoids from microalgae 
Carotenoids are natural pigments that are in numerous plants and organisms (Grand 
View Research, 2016). Carotenoids which originated from algae provide necessary bio 
compounds in different forms that possess significant biological activities with industrial 
interest. There are over 400 publicly recognised carotenoids however some of them 
are used commercially, among the most important are the β‐carotene, α‐carotene, 
lycopene, astaxanthin, lutein, zeaxanthin, canthaxanthin, fucoxanthin, 
violaxanthin etc (Table 3, 4 Appendix A). The most common uses of carotenoids are 
as food colourants and as supplements for human and animal nutrition (Milledge J., 
2012).  
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3.3 Astaxanthin  
An important lipophilic carotenoid pigment is astaxanthin (C40H52O4, 3,3′-dihydroxy-
β, β-carotene-4,4′-dione) belonging to the xanthophylls cluster (Molino et al., 2018). 
Astaxanthin is a bright red secondary carotenoid from the similar family as lycopene, 
lutein, and structurally same to β-carotene, synthesize by aquatic and non-aquatic 
microorganisms like microalgae, plants, yeast, bacteria and attended in many of 
seafood like salmon, trout, red sea bream, shrimp, lobster and fish eggs (Shah et al., 
2016); (Pimentel et al., 2018).  
 
Figure 4: Structure of the carotenoid astaxanthin  
Astaxanthin molecule consists of three completely unlike configurations: 2 
enantiomers (3′R 3R and 3′S 3S) and one meso-form (3R 3′S) with the most 
widespread natural type is that the 3′S 3S form. Artificial astaxanthin consists of a 
mixture composed by the three of them that confer higher stability to the substance 
(Molino et al., 2018). Currently this pigment received from natural (yeast, bacteria, 
krill/ shrimp, microalgae, others) and synthetic sources (synthesised by 
petrochemicals). Though it's a natural substance, however principally utilized in 
synthetic type because of lower production costs, larger purity and stability (Nguyen, 
2013). 
In comparison to other antioxidants and the synthetic form, natural astaxanthin is more 
powerful than vitamin C, Vitamin E etc. (Figure 5). 
 
Figure 5: Natural astaxanthin in terms of other antioxidants, in trapping energy from singlet oxygen 
(Nishida et al, 2007). 
3.4 Health benefits of Astaxanthin 
Below are given some scientifically documented health claims/ effects of astaxanthin, 
see (Appendix A: § Health benefits of Astaxanthin) and Figure 6, (Appendix A: § Health 
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benefits of Astaxanthin) as was presented from BGG a leader manufacturer of natural 
astaxanthin. 
3.5 Industrial applications of astaxanthin 
Astaxanthin has a variety of biotechnological applications for use in the food, feed, 
cosmetic, aquaculture, nutraceutical, and pharmaceutical industries (García et al., 
2017) (Islam et al., 2017); (Khan et al., 2018). Moreover, astaxanthin is extremely 
engaging for necessary industrial markets due to its fascinating properties, like food 
grade, colouring and inhibitor agent. More specifically, it’s used for different aim, as an 
example, in aquaculture field as feed additive for salmons, trout’s, and crustaceans to 
produce their characteristic pink/red colour and for fish’s growth and nourishment of 
ornamental birds (Molino et al., 2018). 
Astaxanthin is well-known to possess powerful antioxidant and anti‐inflammatory 
activities capable of preventing or decrease protein degradation, macular 
degeneration, rheumatoid arthritis, cardiovascular diseases, neurodegenerative 
diseases, like Parkinson's, and cancers (Table 3, Appendix A) (García et al., 2017); 
(Islam et al., 2017); (Khan et al., 2018).  
Synthetic astaxanthin has a cost of about 1000 $/kg, whereas the natural one, is 
reached of 2,500-7,000 $/kg. Most commercially available astaxanthin are synthetic 
(about 95%-99%) and only a little fraction of astaxanthin (<1%) currently derives from 
natural origins (Shah et al., 2016). In the last years, due to its precious properties of 
natural astaxanthin has reached an increasing market trend. A remarkable increase in 
the market of the astaxanthin is expected to reach more than 700 million euro in 2022 
(Research and Markets, 2017). Within the last years, many projects are carried out to 
clarify the feasibility of astaxanthin extraction from natural sources (Shah et al., 2016). 
Also, Valuemag have conceived a technique and a method with main scope targeting 
the dramatic reduction of cost on astaxanthin able to cultivate in a minimum possible 
cost and further the feasibility of the proposed extraction techniques of this natural 
compound.  
3.6 Haematococcus pluvialis - as a major source of astaxanthin 
According bibliography, there are several microalgae strains that are suggested as 
potential sources to produce astaxanthin, such as Chlorella sp., Chlorococcum sp. and 
Scenedesmus sp. (Del Campo et al., 2004); (Ma and Chen, 2001); (Qin et al., 2008), 
D. Salina, H. Pluvialis. However, the accumulation of astaxanthin inside 
Haematococcus pluvialis cells exceeds any other microalgae strain (see Table 5, up 
to 4% of dry biomass), in response to stressful environmental conditions (Khan et al., 
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2018), and thus it is the most preferred species for large scale natural astaxanthin 
production and exploitation (Zhekisheva et al., 2005). 
Table 5: Microorganism sources of astaxanthin (Ambati et al., 2014). 
Sources Astaxanthin (%) on the Dry Weight Basis 
Chlorophyceae  
Haematococcus pluvialis 3.8 
Haematococcus pluvialis (K-0084) 3.8 
Haematococcus pluvialis (Local isolation) 3.6 
Haematococcus pluvialis (AQSE002) 3.4 
Haematococcus pluvialis (K-0084) 2.7 
Chlorococcum 0.2 
Chlorella zofingiensis 0.001 
Neochloris wimmeri 0.6 
Ulvophyceae  
Enteromorpha intestinalis 0.02 
Ulva lactuca 0.01 
Florideophyceae  
Catenella repens 0.02 
Alphaproteobacteria  
Agrobacterium aurantiacum 0.01 
Paracoccus carotinifaciens (NITE SD 00017) 2.2 
Tremellomycetes  
Xanthophyllomyces dendrorhous (JH) 0.5 
Xanthophyllomyces dendrorhous (VKPM Y2476) 0.5 
Labyrinthulomycetes  
Thraustochytrium sp. CHN-3 (FERM P-18556) 0.2 
Malacostraca  
Pandalus borealis 0.12 
Pandalus clarkia 0.015 
 
During this field, H. pluvialis will be thought of a hopeful source of astaxanthin because 
of its ability to accumulate high quantities regarding other sources and H. pluvialis 
derived natural astaxanthin corresponds to < 1% of the commercialized amount 
(Molino et al., 2018). Dried biomass of Haematococcus pluvialis has been 
commercialized as astaxanthin rich source until nowadays. 
3.6.1 Haematococcus – Microalgal culture conditions for growth and 
carotenogenesis  
Haematococcus pluvialis (Chlorophyceae, Volvocales) is considered as the best 
natural source of astaxanthin and the principal commercial organism of this product, 
under stress conditions (Shah et al., 2016); (Mobin and Alan, 2017). H. pluvialis is 
unicellular freshwater strain of green microalgae with a unique life, which is divided in 
two stages (Boussiba, 2000).  
Photoautotrophic, heterotrophic and mixotrophic (based on growth condition), indoor 
or open raceway ponds or closed photobioreactors are used for H. pluvialis cultivation 
(Mobin and Alan, 2017). For commercial production and exploitation of astaxanthin, 
two stages of cultivation strategy are costumed. First step involves growing the algal 
green biomass and the second stage involves producing astaxanthin by red biomass.  
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More specifically, the first refers to a green in which the microalgal cells constantly 
divide and proliferate, composing chlorophyll. The second refers to a red stage in which 
cell division stops and chlorophyll levels do not fluctuate, consequentially in a 
continuous increase of astaxanthin content and cellular dry weight (Panis et al., 2016) 
(see Figure 7). 
 
Figure 7: ‘Green stage’: actively growing H. pluvialis, ‘Red stage’: H. pluvialis that have accumulated 
astaxanthin as a result of nutrient starvation and adverse environmental conditions (Lorenz and Cysewski, 
2000); (Kristoffersen et al, 2012)  
In order Haematococcus pluvialis to transit from stage one (‘green stage’) to stage 
two (‘red stage’), specific stress conditions during cultivation are needed such as light 
density, high temperature, pH, salt concentration and nutritional stresses (Boussiba 
and Vonshak, 1991); (He et al., 2007); (Markou & Nerantzis, 2013). The extremely 
complicated and dynamic composition of cell-wall permits H. pluvialis to survive in 
hostile surroundings, however on the other hand represents an issue once H. pluvialis 
biomass must be processed to extract valuable intracellular compounds like 
astaxanthin (Molino et al., 2018). The cellular composition of H. pluvialis have obvious 
changes between of these two stages of cultivation (Mobin and Alan, 2017), is shown 
at Table 6. 
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Table 6: Ceccular composition of H.pluvialis biomass in two cultivation stages, ‘’green’’ and ‘’red’’ (Mobin 
and Alan, 2017). 
 
During this phase, “red phase”, due to the colour transition from green to red, H. 
pluvialis will increase its astaxanthin synthesis from the lower content within the green 
part (0.5% on dry basis) until the range of 1.5% to 3 on dry basis (Cerón et al., 2007), 
can accumulate up to 5% DW of astaxanthin.  
3.7 Astaxanthin, from Haematococcus pluvialis, in human and animal 
health  
Several researchers have been investigating the health effects of microalgae, with 
positive outcomes regarding some types of cancer, central nervous system, 
cardiovascular system, inflammation and antioxidant, antibacterial and antiviral activity 
among many others (Pimentel et al., 2017). 
Astaxanthin provide diverse human health benefits with nutraceutical implementation. 
Enough bibliography data is obtainable with evidences based in vitro and animal 
models (Shah et al., 2016). The effect followed of astaxanthin from the strain 
Haematococcus pluvialis in animal and human is presented in Table 7, Appendix A.  
3.8 Photobioreactor approach for H. pluvialis 
Firstly, H. pluvialis is that the best well known producer of the carotenoid astaxanthin 
with worthy value, approximately to € 4000 per kg as a result this product will 
completely excuse detrimental cultivation systems which required for this organism 
(Shah et al., 2016).  
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Secondly, H. pluvialis is responsible for astaxanthin formation and deposition of 
triglycerides under stress/extreme conditions. It has been shown that these two 
reactions are closely related for deposition of astaxanthin inside lipid bodies to confer 
its protective function (Solovchenko, 2015). 
Thirdly, H. pluvialis is a mixotrophic alga with extremely beneficially development in 
biorefineries approach. H. pluvialis can use carbon sources (CO2 etc) as a result there 
is reduction of the cultivation costs and/or acceleration of the cultivation (Wu et al., 
2013); (Shah et al., 2016).  
These three aspects of H. pluvialis make it an extraordinary suitable strain to produce 
algal and further the exploitation of astaxanthin with the technology of biorefineries 
producing high value-added final products. According to the previous claims about H. 
pluvialis and since it is possible, at this current study we suggest this microalgae strain 
to combine with the technology VALUEMAG for production and exploitation of 
astaxanthin as a raw material. 
3.9 Challenges 
Nowadays societies are turn to “green” and environmentally friendly solutions as a 
result natural astaxanthin form H. pluvialis constitute to be more attractive than the 
synthetic form due to structure, source, strength, efficacy, superiority and functions, 
wide range of application in several sectors, security and safety as a natural compound 
(Shah et al., 2016). 
There are four main areas where further progresses are needed. Three key areas of 
focus should be: 
1. cost and efficiency of the cultivation, harvesting, infrastructure system 
✓ Firstly, due to the complicated life cycle of H. pluvialis, it is noteworthy to 
maximize the algal cell production and efficacy in the "green stage" of the 
culture to maximize astaxanthin yield from the "red stage". 
✓ Lower amount of consuming water and lower probability of contamination. 
✓ Reutilization of carbon dioxide and nutrient resources at the production of 
valuable products could help decrease cultivation costs (Shah et al., 2016). 
2. good practice of cultivation and controlling predators 
3. isolation, purification, quantification of astaxanthin with economical friendly 
solutions and generally recognised as safe (GRAS) (Shah et al., 2016). 
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4. and exploitation of the abundant bioactive compounds, that can be 
extracted from microalgae. 
Improvements at these issues can overcome the main drawback, the cost of 
production of astaxanthin by H. Pluvialis (Shah et al., 2016). At the end, the main 
challenge of this whole process is to add value to final products (Pimentel et al., 2017). 
This can be reached in several different ways, namely, by 1. exploring and 
development new natural raw materials that are not only rich in functional and bioactive 
compounds but also provide additional properties that the current ones 2. utilization 
these molecules in a viable way 3. processing them through green procedures and 
eco-friendly processes, with low or neither environmental impact and 4. dissemination 
of novel solutions and distributing products that come from consumers demand and 
expectations (Pimentel et al., 2017). Technology of Valuemag has developed to face 
all these challenges.  
3.10 Current status of microalgae at the market  
The total chemical composition of microalgae prepares them as valuable bio-
sustainable ingredient for a wide range of applications, with more interest at the sector 
of industries in which the ingredients used in the formulations; whether as active 
substances, excipients, or additives. All of these are elements of high added value and 
differentiation of a final product (Pimentel et al., 2018).  
At the market of food additives and supplements, microalgae are dominated. The forms 
which are often used for food additives are either as dry biomass powder or as 
extracts by bioactive compounds like PUFA's and carotenoids. At the other hand, food 
supplements are manufacture like powders and in formulations as oils, tablets 
(Molino et al., 2018). 
3.10.1 Regulations issues  
Food Safety Regulations in the European Community (EC 178/2002) and the Novel 
Food Regulation (EC 258/97) are regulated the microalgae products, production and 
selling, which intended for use in food and feed sector. Also, food and feed products 
based in microalgae, which are destined for selling, are regulated by the Federal Food, 
Drug and Cosmetic Act (FD&C) and by the Dietary Supplement Health and Education 
Act (Molino et al., 2018). 
3.10.2 Final cost 
The composition of the microalgae and the percentage of their bioactive compounds 
(EPA/ DHA, astaxanthin, lutein etc) play a crucial role for microalgae final products 
cost. Moreover, the type of cultivations (open or closed systems) is another important 
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issue that have an impact at the cost of production and after to the final product (Molino 
et al., 2018).  
3.11 Current status of astaxanthin in the market  
Below are listed in the Table 8, the main microalgae products of astaxanthin which 
currently approved in Europe and by the U.S. Food and Drug Administration (FDA) 
with their applications sectors, characteristics, with regulations and prices: 
 
Table 8: Astaxanthin biomass and products applied in food, feed, and food supplements, authorized by EU regulations and 
the FDA (Li et al., 2011); (García et al., 2018); (Norman et al., 2018). 
Products Name Application Characteristics Regulations Price 
H. pluvialis meal Color additive for 
fish feed 
(salmonids) 
Dry and comminuted solid biomass 
containing not less than 1.5% 
astaxanthin 
CFR-TITLE 21-FDA US$489/kg 
Astaxanthin Color additive for 
fish feed 
Physical state, solid, 0.05 percent 
solution in chloroform Astaxanthin 
content minimum 96% 
CFR-TITLE 21-FDA €99/kg (astaxanthin 
content: 0.5%) 
Astaxanthin-rich 
oleoresin from H. 
pluvialis 
Novel food and 
food supplement 
Astaxanthin is extracted by CO2-SFE 
or diluted ethyl acetate using olive 
oil, sunflower oil or medium chain 
triglycerides. 
Protein 0.3–4.4% 
Carbohydrates 0–52.8% 
Ash 0.0–4.2% 
Fiber <1% 
Fat 42.2–99% 
Total astaxanthin 2.9–11.1% 
All-trans astaxanthin 79.9–91.5% 
9-cis astaxanthin 0.3–17.3% 
13-cis astaxanthin 0.2–7.0% 
Beta-carotene 0.01–0.3% 
Lutein 0–1.8% 
Canthaxanthin 0–1.30% 
 
Regulation (EC) 
2017/2470 Directive 
2002/46/CE 
€499/kg (astaxanthin 
content: 5%) 
 
The most common forms of astaxanthin as a raw material, bulk of astaxanthin, are 
represented at the following (Figure 8) with their possible uses and industrial 
applications. 
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 Figure 8: Forms of astaxanthin for industrial applications. Oil extract, for softgels capsules, cosmetics 
applications. Powder, for hard capsules, tablet. Water-soluble, for beverages, liquid nutraceutical 
supplements. Beadlet, for dietary supplements in powder sachets. Biomass, for hard capsules, tablet. 
Softgel Capsules, ready-made soft capsules ( http://www.fujichemical.co.jp/english/ ) 
3.12 Nowadays applications of H. Pluvialis 
 
• Dietary supplements containing Haematococcus astaxanthin approved for 
use in human in the US, the EU, Japan, Korea and many other areas in the 
world. Also, food supplements have been shown to be safe for humans’ 
consumptions and have been widely used for over 15 years as dietary 
supplements without the negative side effects of their supplementation (Yang 
et al., 2013). As component for food supplements, species like H. pluvialis 
utilize in the nutraceutical field because of the high concentration of vitamins 
and antioxidant properties (Molino et al., 2018). 
• Aquaculture/ animal feed, for the application of H. pluvialis in nowadays. 
Primary proteins, vitamins, carotenoids and omega-3 fatty acids which can be 
received from this strain in a worthy content are responsible for uses at the 
aquaculture sector. Currently, the Food and Drug Administration has already 
approved the use of H. pluvialis in the red phase in the animal feed market and 
especially in aquaculture as a coloring additive for the feeding of shrimps and 
salmonids (Udayan et al., 2017); (Shah et al., 2016). Dry biomass or as 
astaxanthin extracts, dry and committed material within the form of oleoresin 
(rich in astaxanthin) extracted using the CO2-SFE technique, are the types/ 
forms that utilized at present (Molino et al., 2018).  
• In the cosmetics field, as colouring agents and for UV protection with the high 
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content of carotenoids. In addition, H. pluvialis with an extremely good 
production of lipids, will be used to produce for skin like softness (Molino et al., 
2018). 
3.13 Results from Valuemag 
Regrettably, the market for astaxanthin dominated by synthetic forms. For the purpose 
to promote the natural form of astaxanthin from microalgae strain H. pluvialis, there 
has been applied green and safe extraction techniques using generally recognized as 
safe (GRAS) solvents like ethanol and acetone or extraction method with CO2-SFE 
(Molino et al., 2018).  
Several studies at bibliography have presented experiments on supercritical CO2 
extraction for the maximum recovery of astaxanthin from Haematococcus pluvialis. 
Results of these different studies are showed that the recovery efficiency of 
astaxanthin was determined at 84%, 92% and 97% with modified optimal conditions 
for the temperature and pressure or the presence of co-solvents and concentration of 
them respectively (Panis et al., 2016). 
Results of the proposed magnetic photobioreactor of Valuemag as shown, the 
maximum recovery of astaxanthin (~94%) was found without co-solvent at 550 bar 
and 50oC. However, a comparable result was achieved with co-solvent (~92%) at 
550 bar and 65oC. Also, with co-solvent, the highest purity (~18%) was achieved with 
an extraction time of 40 min at 80oC and 400 bars. Without co-solvent, the highest 
purity (~34%) was found with an extraction time of 80 min at the same pressure and 
temperature (Molino et al., 2018).  
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 4. THE MARKET 
4.1 Total market of algae products – The size 
In the last years, there is a growing concern of customers on ‘food with nutritional value’ 
or 'healthful' products. In accordance with this fact, there is an increasing rate at the 
demand for these products which are promote better health, are increase longevity and 
are protect against the beginning of chronic diseases. Consequently, the utilization of 
microalgal biomass/raw material or its derived bioactive compounds have become a 
novel approach for the research and development food products with nutritional value 
(Gouveia et al., 2008); (Garcia et al., 2017). 
 
According to the most recent obtainable statistics from FAO (Food and Agriculture 
Organization), approximately 23.8 million tons of macroalgae ($6.4 billion) and other 
algae are harvested annually. The main producing countries are China (54%) and 
Indonesia (27%), followed by the Philippines (7.4%), Republic of Korea (4.3%), Japan 
(1.85%), and Malaysia (1.39%) (FAO, 2012). In Asian countries, macroalgae are 
traditionally used as source of food, for medicated functions, or as fertilizers. Also, they 
have uses as raw material in animal feed (Pimentel et al., 2017). Generally, according 
to international trends and habits, there is an increasing demand for edible algae and 
algae-based products (Wells et al., 2017). 
 
Searching the current market size of microalgae‐based products, dried whole algae 
Spirulina have the largest share, more than 12000 tons of Spirulina biomass are 
produced each year (at about 30 US$/kg) mainly in China, India and Taiwan (Garcia et 
al., 2017). Worldwide, Chlorella producers cultivate an approximate number of 5000 
tons each year. Following, D. salina (about 3000 tons for carotene), A. flosaquae 
(about 1500 tons for food), H. pluvialis (about 700 tons for astaxanthin), C. cohnii 
(500 tons of DHA) and Shizochytrium (20 tons of DHA) (Garcia et al., 2017). 
 
As per Transparency Market Research (2018), ‘’the global nutraceutical market 
(including functional food and beverage ingredients, dietary supplements, personal 
care and pharmaceuticals), which was valued at US$ 182.60 Bn in 2015, will rise to 
US$ 278.96 Bn by 2021, exhibiting a CAGR of 7.3% for this period ‘’. As a result, the 
research and development of new functional food and beverages with added 
ingredients will be faced a great interest in the coming years (Bagchi and Nair, 2017). 
There are also hopeful market opportunities for some nutraceuticals, with carotenoids 
to play a crucial role. Therefore, the global market for carotenoids is projected to reach 
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US$ 1.7 Bn by 2022 
(https://www.strategyr.com/Marketresearch/Carotenoids_Market_Trends.asp). Global 
market for both synthetic and natural source astaxanthin in aquaculture, nutraceuticals, 
cosmetics, food and beverages is projected to reach 670 tons valued at US$ 1.1 Bn by 
2020 (Garcia et al., 2017). 
 
Below at Chart 1, 2 (Appendix B) represented the expected increase in the global algae 
products market, based on some market reports.  
4.1.1. Trends of this market 
Below are given the key driving factors which will be affect the algae products market:  
• Multiple industry coverage/ Growing demand for algae products from the 
nutraceuticals and pharmaceutical industries 
Microalgae have gathered much attention as important source of bioactive molecules 
due to wide range of applications and higher productivity when compared to plants and 
microbes (Khan et al., 2017). So, the demand for biological compounds is growing 
dramatically because of their unique features such as secure utilization, antioxidant 
properties and durability under stress conditions like variable light, pH, and 
temperature conditions. Also, the increasing utilization of products from microalgae, as 
algae meal in aquaculture, as ingredients to dietary supplements, nutraceuticals and 
cosmetics are driving the growth of algae products market. 
• Increase in consumer awareness concerning the health benefits of algae-
based products 
Food & beverage products which originate from algae are gaining the favour of 
consumers due to health benefits of these products. The health benefits provided by 
these products refer to brain health, eye health, skin health and UV protection, 
cardiovascular support etc. 
• Alternate food source and food ingredient  
Increasing consumer choice for alternative protein sources has also drive to the 
demand for algae-based food ingredients in ordinary food and health drinks. 
Additionally, the vegetarian tendency in North America and Europe is anticipated to 
led the demand for algae products in food, leading to the development of this market 
(Markets and Markets, 2018). 
• The need to shift from fossil fuel resources to renewable energy sources. 
Rise concerns about carbon-based emissions is causing an increase in use of biofuels 
derived from algal sources, consequently driving in raise in the global algae market. 
Worldwide, many governments are encouraging production of biofuels derived from 
algae. Thus, the associated policies put forth by such bodies are causing the global 
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algal market to grow at a fundamental rate. In the next few years, this market is 
expected to attend a potent expansion, thanks to a rising awareness to use biofuels 
derived from algae (Transparency Market Research, 2018) 
• Furthermore, as the adoption level of algae products by consumers is 
increasing,  
it helps companies innovate and develop product lines for algae products, which has 
further contributed to the growth of the algae products market (Markets and Markets, 
2018). 
4.1.2. Market segments 
Table 9: Segmentation of the global algae products market (Markets and Markets, 2018) 
 
 
 
 
On the basis of Application 
-Food & beverages 
-Nutraceuticals & dietary supplements 
-Feed 
-Personal care products 
-Pharmaceuticals 
-Others (pet food, fortified food, and infant food) 
 
 
On the basis of Type 
-Lipids 
-Carrageenan 
-Carotenoids 
-Algal protein 
-Alginate 
-Others (algal flour, dried algae, and agar) 
 
 
On the basis of Source 
-Brown algae 
-Blue/green algae 
-Green algae 
-Red algae 
-Others (yellow-brown algae and golden algae) 
On the basis of Form -Solid 
-Liquid 
 
On the basis of Region 
-North America 
-Europe 
-Asia Pacific 
-RoW (South America, Middle East & Africa) 
 
The global algae products market is segmented based on:  
o Application (nutraceuticals, food and feed supplement, pharmaceuticals, 
paints & coatings, pollution control and others) (Credence Research, 2018). 
 
According the report Credence Research (2018), among these applications, 
nutraceuticals accounted the global algae products market in 2016 with the major 
market share (Figure 9). Algae products with uses as nutraceuticals containing the 
dietary supplements, food supplements and non-food supplements such as tablets, 
capsules, etc (Credence Research, 2018). Food & feed supplements formed the 
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following part, the second highest market share of global algae products market. Algae 
contain proteins that can be used in various foods and feed application, for example 
like as protein source for fish meal in aquaculture. Therefore, this sector is expected 
to create high demand for algae products in the market (Credence Research, 2018); 
(Research and Market, 2017). Other applications of algae products are also expected 
to boost the market during the following period from 2016 to 2023 (paints & colorants, 
pollution control, and pharmaceuticals) (Credence Research, 2018). 
By applications, ‘’aquafeed occupied the largest market share in 2015, accounted for 
about 40%, and will continue to maintain in the coming period due to the growing 
demand for fish‘’ (Gos Reports, 2016).  
 
 
Figure 9: Global Algae Products Market Revenue, By Application, 2015 ($ Mn) (Credence 
Research, 2018) 
 
Also, other sources claim that based on application, the food & beverage segment 
accounted with the highest market share, followed by the nutraceutical and dietary 
supplement segment, in 2017 (Markets and Markets, 2018). 
o Product type (hydrocolloids, carotenoids, omega-3 PUFA, spirulina, chlorella, 
and others),  
The algae products market, depending on their type, is divided into segments like 
lipids, carrageenan, carotenoids, algae protein, alginates and others (that include dried 
algae, algal flour, and agar) (Markets and Markets, 2018). Lipids figured the largest 
market share in 2017.  This can be attributed to algae as alternative sources to produce 
lipids in high content and fulfil the growing demand from the vegan population (Markets 
and Markets, 2018). 
o Source 
Based on source, brown algae-derived products figured a larger market share in 2017, 
followed by blue-green algae. Brown algae contributing to the growth of this market 
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because seaweed have the required properties for nutraceutical applications like anti-
hypothyroid, anti-rheumatic, antibacterial, anticoagulant and antioxidant. Other 
products that can be extracted from brown algae are carotenoids and lutein, thus 
rendering it an extremely used algae type (Markets and Markets, 2018). 
o Form  
Based on form the algae products market has been segmented as liquid or solid form 
(Markets and Markets, 2018). 
o Region  
Geographically, the market is segmented into five major geographies, namely North 
America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (Markets and 
Markets, 2018). 
North America are mentioned with the largest quota of the algae products market in 
2017 (Figure 10) (Markets and Markets, 2018). The large share of North America is 
principally attributed to the growing demand of nutraceutical market. Essential factors 
of this demand are rendered in rising of aging population, increasing healthcare 
awareness, and higher incidence of allergies and intolerance (Markets and Markets, 
2018).  North America is also anticipated to push high demand for algae products soon 
due to the existing algae research industries in the region which are increasingly being 
developed (Research and Markets, 2017) 
 
Figure 10: Algae Products Market, by geography, 2017-2022 (Meticulous Market Research, 2018). 
Europe accounted to be the largest consumer of algae products worldwide (Research 
and Markets, 2017) due to the increasing demand for algae from the pharmaceutical 
and nutraceuticals industries in this region. During the following period, additional 
regions such as Asia Pacific, Latin America and Middle East and Africa are also 
expected to provide growth of global algae products market (Research and Markets, 
2017) 
North 
America
Europe
Asia-Pacific
Latin America
Middle East 
and Africa
ALGAE PRODUCTS MARKET, BY REGION 
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 Figure 11: Global distribution of private companies producing commercial food and feed products 
derived from micro-algae (Vigani et al., 2015). 
Leading market participants in the industry over the past 3 years (2014-2017) see 
Appendix B, § Leading market participants in the industry of algae. 
4.2 Total market of carotenoids/ Astaxanthin – The size 
Carotenoids are organic pigments that are in several plants and organisms (Grand 
View Research, 2016). Global carotenoids market demand was 1.150,4 tons in 2015 
with increasing demand for human nutrition and skin care cosmetics in emerging 
countries such as China, India, South Korea, Brazil, Singapore, and Thailand. 
Increasing the sector of Research and Development of valuable natural carotenoids is 
anticipated to create new growth opportunities for this market and industrial acceptance 
(Grand View Research, 2016). 
Astaxanthin is utilized on a large scale due to its functional attributes, easy availability 
and industrial exploitation in almost all the sectors (Algae Industry Magazine, 2016). 
As animal feed components/ ingredients, human antioxidants and for the colouring of 
shrimps, salmon, and trout, astaxanthin is predicted important growth over the 
following period (Grand View Research, 2016) (Fig. 12). 
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 Figure 12: Astaxanthin Market, by application and by source (Global Market Insights, 2018). 
‘’The global astaxanthin market size was more than 250 kilo tons in 2014, and is 
expected to reach 340 tons by 2020, and is likely to grow at a CAGR of over 7% from 
2016 to 2023‘’ (Algae Industry Magazine, 2016). Below, based on some reports about 
global carotenoids and global astaxanthin market, the following foreseen results are 
presented (Chart 3,4,5,6,7 Appendix B). 
4.2.1 Trends of this market 
4.2.1.1 Carotenoids 
The market of carotenoids is driven by factors such as: 
• increasing health consciousness among the customers/ and increasing 
consumer preference for natural products over synthetic products.  
Dietary supplements are anticipated to reach significant acceptance of the consumers 
due to rising health consciousness and adapting a different lifestyle. Carotenoids are 
key additives which found application in human health supplements because of their 
benefits in immunity enhancement and richness in vitamins (Grand View Research, 
2016). Some of the prominent trends that the market is witnessing include lucrative 
opportunities through development of high-value natural carotenoids and rising 
consumer interest towards naturally sourced products (Research and Markets, 2017). 
• rising end-use applications of carotenoids  
-The growth of the carotenoid market is attributed to their increasing applications in 
pharmaceuticals, cosmetics, food, and animal feed (Markets and Markets, 2016).  
These products act as antioxidants within the body supporting eye, skin, 
cardiovascular health and cancer prevention. Potent development of pharmaceutical 
and cosmetic industry in emerging countries such as China, India, and South Korea 
will generate additional opportunities at this market in the future. Furthermore, 
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GlaxoSmithKline, Pfizer, Sanofi and Novo Nordisk will drive the demand because they 
are consisted of some of larger pharmaceutical companies with strong presence in the 
industry area (Grand View Research, 2016). 
- The demand of carotenoids in the animal feed sector is expected to introduce 
increase due to the industrialization of pork, poultry, and aquaculture business and the 
growing focus on the quality and appearance of meat and fish products (Algae Industry 
Magazine, 2016) 
- Moreover, an extra factor is the population growth driving the demand for these 
applications. The growing middle-class population, educational development, and the 
rising disposable incomes have driven to increasing consumer awareness concerning 
the health benefits of dietary supplements (Grand View Research, 2016) 
• The rising demand for functional and processed food owing to busy lifestyles 
is expected to positively impact market growth.  
4.2.1.2 Astaxanthin - Growth Drivers 
The astaxanthin market has been gaining importance due to: 
• High demand due to its antioxidant properties and potential industrial 
applications are key agents affirming development of this market. 
• Other prominent factors are estimated to promote growth is the rise in health-
conscious population and alteration demand for natural food colouring agents 
without adverse effects by synthetical sources. People in developed countries 
are more focused on consuming food products derived from natural sources 
(Grand View Research, 2017) 
• Increasing consumer requirements on personal care and cosmetic products 
along with rising awareness concerning nutraceuticals will drive the astaxanthin 
industry growth. Also, propelling demand for cosmetics with anti-ageing 
properties as other products by the reason of developing life expectancy 
(Global Market Insights, 2018). 
• In addition, astaxanthin is gaining popularity and acceptability in numerous 
wellness spa service providers and cosmetics manufacturers owing to its skin-
friendly and anti-oxidant properties (Global Market Insights, 2018) 
• Regulatory policies over the use of synthetical compounds is also expected to 
fuel the growth of global astaxanthin market in the near future (Future Market 
Insights, 2019) 
• Furthermore, the approval of astaxanthin by the U.S. FDA as generally 
recognized as safe (GRAS) for dietary supplements and approval from various 
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European food agencies has played crucial role in the growth of astaxanthin 
market (Shah et al, 2016) 
• In addition, lack of raw material and inefficient advanced technologies are 
limited the market (Research and Markets, 2017). There is important limitation 
in this industry is raw material resource by the reason that as main raw material 
of natural astaxanthin, microalga (Haematococcus pluvialis) is easily 
interference by pests and diseases (https://thestatetime.com/). 
4.2.2 Market segments 
4.2.2.1 Carotenoids 
The carotenoids market has been segmented, based:  
o on type/ product, as Astaxanthin, Beta-carotene, Lutein, Lycopene, 
Canthaxanthin, Zeaxanthin, and Others (annatto, capsanthin, fucoxanthin, and 
trans-β-apo-8'-carotenal) (Markets and Markets, 2016).  
 Astaxanthin had been represented the largest market share in 2015, followed by beta-
carotene and lutein (http://www.algaeindustrymagazine.com/). The Astaxanthin 
segment dominated the carotenoids market, in terms of value, in 2016 (Markets and 
Markets, 2016).  
o on application, the carotenoids market has been segmented into feed, food, 
supplements, cosmetics, and pharmaceuticals (Markets and Markets, 2016).  
“Animal feed segment led the market with the largest share in 2015 and 
accounted for 41% of the overall revenue share” (Grand View Research, 
2016) (Fig. 13). 
 
Figure 13: Global carotenoids market volume, by application, 2015 (%) (Grand View 
Research, 2016). 
41% 
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“The feed segment is estimated to account for the largest share in the 
carotenoids market in 2016” (Markets and Markets, 2016). 
Based on application, the carotenoids market is led by the feed segment, followed by 
the supplements and food segments. Bodies of animals are not able to produce 
carotenoids as a result these nutrients are added to animal feed providing immunity 
against diseases (Grand View Research, 2016). Along with adding nutrients to the 
feed, carotenoids also increase the palatability of feed 
(http://www.algaeindustrymagazine.com/). All the above will drive growth at the market 
of these essential nutrients at the near future. 
o by source  
By source, market is segregated by synthetic and natural. ‘’Synthetic sources 
dominated the overall industry valued at USD 903.6 million in 2015 and natural sources 
are expected to witness substantial revenue growth at a CAGR of 6.1% from 2016 to 
2025” (Grand View Research, 2016) 
o by region  
 The global carotenoids market is segmented region-wise, these regions include North 
America, Europe, Asia-Pacific, Latin America, and the Rest of the World (RoW) 
(Markets and Markets, 2016). 
Caused by increase of demand for supplements and animal feed in Europe had been 
calculated to occupy the largest market share at the carotenoids globally, in terms of 
value, in 2016 and is anticipated to witness steady revenue growth at a CAGR of 3.8% 
from 2016 to 2025 (Grand View Research, 2016) (Figure 14). According to Markets 
and Markets, 2016 the leading markets for carotenoids in Europe are Germany, 
France, Italy, The Netherlands, and Spain. The leader’s players at the cosmetic 
industry such as L'Oréal, Unilever, Beiersdorf, and Henkel is predicted to play a crucial 
role at the growth of carotenoids market in this region (Grand View Research, 2016). 
North America had accounted the next one largest market share in 2015 and is 
anticipated to grow at the highest CAGR from 2016 to 2021 (Grand View Research, 
2016). In addition, the strict norms are connected to the use of synthetic carotenoids 
laid down by the EU have driven to the natural form of carotenoids market (Markets 
and Markets, 2016). 
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 Figure 14: Carotenoids Market Size, By Region, 2021 (USD Million) (Markets and Markets, 
2016). By Region: North America –22%, Europe – 56%, Asia-Pacific– 19%, RoW – 3% 
(Markets and Markets, 2016) 
In the Asia-Pacific region is predicted to grow from several multinational manufacturers 
the carotenoids market. Moreover, extensive R&D initiatives have been undertaken in 
this region for exploring the applications of carotenoids (Markets and Markets, 2016). 
Asia Pacific is expected to show high profits on account of growing usage and 
exploitation of carotenoids additives in feed, supplement, food, pharmaceutical and 
cosmetic applications. The sector is anticipated to be driven by technological 
advancements, industrial growth in a range of applications, economic growth and low 
costs of production with efficient way in countries such as China, Japan, and India 
(Grand View Research, 2016). 
Key players recognised in the carotenoids market, see Appendix B § Key players in 
the carotenoids market. 
4.2.2.2 Astaxanthin 
Table 10: Segmentation of the global astaxanthin market (Markets and Markets, 2018) 
By Source -Natural (microalgae, yeast, krill/shrimp) 
-Synthetic 
 
By Product 
-Dried algae meal or Biomass 
-Oil 
-Softgel 
-Liquid 
-Others 
 
By Application 
-Nutraceuticals 
-Cosmetics 
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-Aquaculture and animal feed 
-Others 
 
By Region 
-North America (U.S., Canada) 
-Europe (UK, Germany) 
-Asia Pacific (Japan, China, India) 
-Central & South America (Brazil, Mexico) 
-Middle East & Africa (South Africa) 
 
Global Astaxanthin Market can be segmented on the basis of:   
o Source, as natural (microalgae, yeast, krill/shrimp) or synthetic.  
Synthetic source will gain a major share in the market, with over 55% demand rate by 
the end of 2024 (Global Market Insights, 2018).  Natural sources are appreciated to 
witness exponential CAGR of over 24.5% over the following period, 2018-2025 (Grand 
View Research, 2017). 
 
The fundamental growth at astaxanthin from natural sources is attributed to its its 
health benefits for human and animals along with the great preference over the 
synthetic counterpart. Some of aquaculture companies are also supplying natural 
forms, even at a higher price (Global Market Insights, 2018). The primary market of 
synthetic astaxanthin from petroleum is used as animal feed while in contrast the 
natural form is majorly utilized for human uses and consumption. Nevertheless, the 
demand for natural astaxanthin in animal nutrition has been noticing significant 
increase in recent years due to a number of safety issues and concerns which 
associated with the consumption of animal meat treated with petroleum-based 
astaxanthin (Grand View Research, 2017).  
In addition, astaxanthin from natural sources provides better pigmentation for some 
species of fishes instead of synthetic. All these factors will show changes at this market 
in its proliferating sales, further strengthening penetration at this area (Global Market 
Insights, 2018). 
o Product, as dried algae meal or biomass, oil, softgel, liquid and others (Grand 
View Research, 2017).  
Dried algae are expected to dominate the market principally as animal feed due to not 
extra procedures and low cost of the production. This sector had held a revenue share 
of 25.9% of the overall market in 2016 (Grand View Research, 2017). 
 
The segment of soft gels is projected to witness CAGR of over 19.5% over the next 
period. Serious agents that can be ascribed to this development are increased use of 
soft gels in nutraceutical due to ease of administration and easy availability in a variety 
of doses according to the needs (Grand View Research, 2017). 
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 Liquid astaxanthin is also increasingly looking for use as a food coloration factor 
because of its easily miscible nature and low negative effects (Grand View Research, 
2017). 
o Application  
Global Astaxanthin Market can be further segmented based on application 
(Transparency Market Research, 2018). Based on application can be segmented into 
dietary supplements, food & beverages, cosmetics, aquaculture and animal feed 
(Future Market Insights, 2019). 
The major market share of astaxanthin is find applications in aquaculture and in animal 
feed industry (Transparency Market Research, 2018). Increasing government support 
for promoting aquaculture is further reinforcing the product demand as a colorant 
pigment (Global Market Insights, 2018). Also, astaxanthin market from animal feed will 
dominate the industry, in possession of share of the global demand over 40% (Global 
Market Insights, 2018). In the U.S., the segment held a 39.6% share in 2016 (Grand 
View Research, 2017) (Figure 15). 
 
Figure 15: Global astaxanthin market, by application, 2016 (%) (Grand View Research, 
2017). 
 
The application of astaxanthin in the dietary supplements industry accounted for the 
second-largest share in 2016 (Grand View Research, 2016). The numerous health 
benefits, such as cardiovascular and neurological health, provided by the antioxidant 
functions of astaxanthin, coupled with the increasing demand for nutraceuticals, are 
the crucial agents contributing to the exponential growth of dietary supplements 
segment (PRNewswire, 2017). 
39.6 % 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 18:25:40 EEST - 137.108.70.13
A desk research1, at Dietary Supplement Label Database (DSLD), was conducted for 
the purpose of this thesis, focusing on the dietary supplements which contain 
astaxanthin and other synergistic substances. Results indicated that:  
▪ 68 products which contain ‘astaxanthin’ in the product name, with the 
following health claims: Supports joint and tendon health -Supports skin health 
during UV and sun exposure -Supports eye health -Supports anti-aging through 
cellular health -Supports healthy immune function -Supports cardiovascular 
health -Supports the body in recovery from exercise 
▪ 598 products which contain ‘astaxanthin’ anywhere on the label, and 
some of them with omega-3 fatty acids from krill oil and virgin salmon oil. These 
dietary supplements function synergistic with other substances and have the 
following product names like as: Carotenoid Complex, OmegaXanthin Blend, 
Manganese, Super Antioxidant Blend, Krill Oil Blend, Astaxanthin Phospholipid 
Proprietary Blend/ natural Astaxanthin, Wild Alaskan Salmon Oil and 
Haematococcus pluvialis Algae extract. 
 
Astaxanthin is also used in several nutraceuticals products, due to its properties as a 
result this segment is calculated to witness the most profitable growth over the next 
period between 2018-2025 (Transparency Market, 2018); (Grand View Research, 
2017). 
In food and beverages, demand of astaxanthin is used to cover some specific proteins 
from natural sources and forms (Transparency Market, 2018). Moreover, the approvals 
granted by international food agencies, including Canadian Food Inspection Agency 
and European Food Safety Agency will support and promote the industry growth 
(Global Market Insights, 2018). 
Astaxanthin also finds its application in cosmetics & personal care products 
(Transparency Market, 2018).  From bibliography astaxanthin has been reported for 
its high antioxidant and skin-friendly properties as a result it finds applications in 
numerous cosmeceutical manufacturers and wellness spa owners are using it in new 
products and associated therapies. Last but not least, increasing geriatric population, 
prosperity of cosmetic industry, and the alteration to natural cosmeceuticals are factors 
appreciate to expedite growth of this market segment (Grand View Research, 2017). 
                                                          
1 The Dietary Supplement Label Database (DSLD) includes full label derived information from dietary 
supplement products marketed in the U.S. with a Web-based user interface that provides ready access 
to label information. Key words that are used: astaxanthin (product name, ingredient name, brand name, 
manufacturer)  
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 Figure 16: Presentation on industrial training (plant Biotechnology – Algae) (Google, 
accessed 16/5/2018) 
 
o Region 
By Region - North America-25%, Europe-50%, and Asia-Pacific- 25% 
(Transparency Market Research, 2018). 
 
Geographically, global astaxanthin market can be divided into the following regions: 
North America, Eastern Europe, Asia Pacific, Japan, Latin America, Western Europe 
and Middle East and Africa (Future Market Insights, 2019). Globally, among all of these 
previous regions, North America is leader in the commercial production of astaxanthin, 
followed by Asia Pacific and both of them are anticipated to be the most potential 
markets for Astaxanthin manufactures (Grand View Research, 2017). Other countries 
which will contributes at the total production of astaxanthin globally is India, Japan and 
Israel (Transparency Market Research, 2018) 
The Asia-Pacific region was the largest regional market for astaxanthin in 2016 
including China, India and Australia-New Zealand (PRNewswire, 2017). There are 
several factors that will play vital role in the high astaxanthin growth of value over the 
next period like:   
- growth in pharmaceutical industry, especially in developing countries such as China 
and India (Coherent Market Insights, 2018). Attendance of key manufacturers like 
BGG and InnoBio in China, is a noteworthy agent for the potential growth at this region 
(Grand View Research, 2017). According to IBEF, ''US$ 55 billion will be generated by 
the Indian pharmaceuticals industry by 2026'' (Coherent Market Insights, 2018).  
- increasing awareness about natural astaxanthin and a flourishing cosmeceutical 
industry from natural products (Grand View Research, 2017). Countries such as India, 
Singapore, and Malaysia are key regions in Asia Pacific for active wellness tourism 
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and leisure activities. Demand natural oils and cosmetics in spa and wellness centres 
due to low concerns are some other key factors asserting growth from natural products 
(Grand View Research, 2017).  
-demand for animal feed application across the region (Global Market Insights, 2018). 
North America held a substantial market share of 46.5% in 2016 (Grand View 
Research, 2017). The North America market will expose increase because of 
extremely large demand from the dietary supplement industry coupled with growing 
awareness about health benefits (Global Market Insights, 2018). Last but not least, 
presence of organizations such as Natural Algae Astaxanthin Association (NAXA) is 
evaluated to the potential growth the regional market share (Grand View Research, 
2017). 
The market in Europe is the key market for Astaxanthin due to the varied health 
benefits and its demand for uses in animal feed (Markets and Markets, 2016). 
Astaxanthin market is oligopolistic in nature and is dominated by several key players, 
see Appendix B, § Key players of the market of astaxanthin.  
 
Figure 17: A schematic of astaxanthin market by the report Global Market Insights, 2018 (Global Market 
Insights, 2018) 
4.3 Production of natural astaxanthin 
From 2011 to 2016, ''global natural astaxanthin production increased from 
43279 Kg to 73717 Kg, with an average increase rate of 11.24%''. China, 
Europe, North America and Asia are some of the global production regions 
of natural astaxanthin (PR Newswire, 2017). 
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In 2015, ‘’Europe produced about 9.20% of global total natural astaxanthin. 
North America produced 46959 Kg, accounting for 67.12% in 2015’’ (PR 
Newswire, 2017). The largest volume of Haematococcus pluvialis is 
appreciated to have consumed from the global nutraceutical industry in 2017 
accounting for 54.8% and reaching 190 metric tons by 2024 (PR Newswire, 
2018). Despite this, ‘’the emerging market of Food & Beverages for H. 
pluvialis microalgae astaxanthin consumption will witness the fastest CAGR 
between the next period, 2017 and 2024’’ (Industry Experts, 2018); 
(Research and Markets, 2018) 
 
Nowadays, the estimated market value of astaxanthin depending on 
products' purity varies from 2200–6620 €/kg to about 13.240 €/kg pigment 
from H. pluvialis in some cases, while the production cost is estimated at 
about 880 € per kg of astaxanthin from H. pluvialis (Shah et al., 2016)  
4.4 Target Market 
VALUEMAG both seeks and welcomes opportunities to collaborate with 
industry and research groups. Key areas of interest include providing 
ingredients/ raw materials for human and animal health and nutrition, finished 
products for aquaculture and agriculture, and technology for environmental 
remediation.  
 
Firstly, target audience is distributors and further: 
• Astaxanthin manufacturers 
• Food ingredients manufacturers 
• Astaxanthin importers and exporters 
• Astaxanthin traders, distributors, and suppliers 
• Astaxanthin raw material suppliers 
• Astaxanthin end-product manufacturers 
• Associations and industry bodies such as the Food and Drug 
Administration (FDA), the European Food Safety Authority (EFSA), Natural 
Algae Astaxanthin Association, and other food & safety associations. 
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5. THE COMPETITION 
5.1 Direct Competitors  
Although downstream demand for natural astaxanthin is too much, there are only 
several major suppliers in this industry.  
➢ The major players covered in Global Natural Astaxanthin Market report - 
Cyanotech, Fuji, Parry Nutraceuticals, Algatechnologies, Biogenic, Jingzhou 
Natural Astaxanthin, Igene, Yunnan Alphy Biotech, ADM, BGG, Piveg.  
➢ Main Product Types covered in Natural Astaxanthin industry - Astaxanthin 
Oleoresin, Astaxanthin Powder.  
➢ Applications covered in Natural Astaxanthin industry - Nutraceuticals, 
Cosmetics, Food & Beverages, Feed (Research Reports Inc. 2018). 
Algatech, Cyanotech and Fuji are the three leading astaxanthin producers have 
combined forces and established the Natural Astaxanthin Association (NAXA) for the 
purpose of imparting awareness regarding the differences between the natural and 
synthetic forms of astaxanthin (Industry Experts, 2015); (https://astaxanthin.org/). 
Below are given the new entrants in the production of astaxanthin from H. pluvialis. 
Table 11: New Entrants in the H. pluvialis Astaxanthin Sector (Industry Experts, 2015). 
 
Below at Table 12, Appendix C is given an extensive research of the leading 
commercial companies and their H. pluvialis - derived astaxanthin with the culture 
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system which they use, the official company name, the country, the brand name at the 
market, the forms of bulking and the application area. 
In addition, for each one of the direct competitors, are presented information about 
their entity, the market segments they are active in, their product/services and business 
model. Regarding entities, are mentioned the maturity and type of their business, their 
business model. Regarding market segments, are mentioned their market position 
(leader, large, niche, small) (Appendix D, § Company Profiles). 
After the investigation of the other competitors and as shown in Table 9, the culture 
systems of astaxanthin which are exist on the market are mainly focused mainly on 
the common/ordinary cultivation systems. It has been noticed that neither company 
has so far exploited the effect of magnetic cultivation which Valuemag proposed. 
In addition, it was observed that on global market, there are various market players 
with leader position, experience and dynamic presence in the field of algae production; 
and especially at the production of astaxanthin from H. pluvialis. These players are 
likely to increase competition. 
Owning to its unique way of cultivation and the innovations of the project, Valuemag 
permit optimal cultivation, enhance biomass productivity and dramatically lower costs 
of biomass production. So, that bringing natural astaxanthin from H. pluvialis very close 
to the market, with environmentally and socially sustainable issues. 
5.2 Indirect competitors 
Below are given the alternative natural sources, from which can be produced 
astaxanthin, and the top market players of them. 
 
Table 13: Astaxanthin Production from natural sources and leading commercial companies  
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5.2.1 Microalgae source of Astaxanthin, compared with other natural sources  
At this time, the primary source of astaxanthin and carotenoids are synthetic forms 
produced by chemical means. There are also natural sources available from 
processed krill, crawfish and a yeast called Phaffia (https://www.cyanotech.com/). At 
these other natural sources contain relatively low astaxanthin concentration, from 
0.3mg/100g. in crawfish and lobster to 800mg/100g. in Phaffia Yeast, as we can at 
Table 14. The competitive advantage and the benefits of using an algae source of 
astaxanthin is that the other natural forms like the krill, crawfish and Phaffia sources 
contain low concentrations of astaxanthin (Ambati et al., 2014). 
Table 14: Sources of natural astaxanthin with the average content ( http://www.fujichemical.co.jp/english/) 
Source Average Astaxanthin Content 
Lobster, crawfish 0.3mg/ 100g. 
Salmon 3mg/ 100g. 
Krill 4mg/ 100g. 
Phaffia Yeast 800mg/ 100g. 
Heamatococcus Pluvialis Microlagae 6,000mg / 100g. 
 
Also, feeds may require so much addition of these products for effective pigmentation 
that it adds unwanted bulk and ash, decreases palatability, and alters the nutrient 
balance of the diet (https://www.cyanotech.com/). The astaxanthin derived from 
Haematococcus algae is the most concentrated source of natural astaxanthin that is 
available (Shah et al., 2016).  
5.2.2 Natural Astaxanthin, compared with Synthetic  
The companies that are active in synthetic astaxanthin are: BASF SE (Germany), Divis 
Laboratories Limited (India), Royal DSM NV (The Netherlands), Zhejiang Medicine 
Co., Ltd. (China), Zhejiang NHU Co., Ltd. (China) (Research and Markets, 2018) 
(Industry Experts, 2018) (Table 15). 
Table 15: Synthetic Astaxanthin production and leading commercial companies  
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Synthetic astaxanthin has 20 times lower antioxidant capacity than its natural 
counterpart and to date has not been approved for human consumption (Lorenz and 
Cysewski, 2000); (Koller et al., 2014). Additionally, about the safety of using synthetic 
astaxanthin for direct human consumption there are concerns and uncertainties due to 
both different stereochemistry and possible carryover of synthesis intermediates (Shah 
et al., 2016). 
According to market research of Grand View Research at 2017, ‘’the market for 
synthetically produced astaxanthin is calculated to be impacted with negative way by 
the increasing demand for the natural astaxanthin counterpack‘’. Moreover, 
astaxanthin which is originated from chemical synthesis is also expected to decrease 
the market share of this segment due to the requirement of high capital and labour. As 
a result, these reasons make natural astaxanthin a preferred choice for high-end 
markets with competitive advantage from synthetic one. 
5.2.3 Other Indirect competitors 
In addition, there are other indirect competitors of astaxanthin on the market that have 
to do with the potential uses of this compound. For example, there are other 
substances that are used as colourant in food industries or in aquaculture. Also based 
on astaxanthin antioxidant, anti-inflammatory and anti-aging functions there are other 
bioactive compounds that can be incorporated into nutritional formulations, dietary 
supplements, nutraceuticals and cosmetics. All of the above factors may be escalated 
the competition of astaxanthin. 
5.3 SWOT ANALYSIS 
SWOT analysis is a framework used to estimate a company's or product (raw material) 
competitive position and to improve strategic planning. Recognizing core strengths, 
weaknesses, opportunities and threats based on fact analysis, new prospects and 
fresh ideas. SWOT analysis evaluates internal and external agents, as well as current 
and future potential (https://www.investopedia.com/). See, Appendix C. 
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6. THE BUSINESS MODEL 
 
The cultivation and production of microalgae will take place either in Cyprus or in 
Greece with the new magnetic cultivation system and with a genuine ecological crop. 
The company will be responsible to undertake the Quality Control department and will 
proceed with the acquisition of all relevant quality certificates. Our products will meet 
the most rigorous global quality and safety standards and will have all the appropriate 
regulatory approvals (self-affirmed GRAS and produced in a certified facility, Non-
GMO project verified, USDA Organic). 
Finally, our main concern will be to find distributors in North America, Europe and Asia 
to sell the astaxanthin as raw material, in bulking. At the first two years Qualia is aimed 
to find distributors in Europe. Afterwards, at the 3rd year in North America and 4rd and 
5rd year at the Rest of the World, as we explain at the following sector (§7. Funding’s 
& Revenues, market share).  
Group of Companies of Qualia has a broad and comprehensive coverage of all areas 
of the modern Health Care Sector and build collaborations to foster innovation with 
Research Institutes and Universities. Qualia Pharma was founded in 2009, focusing 
exclusively in the Health Care sector and providing a broad range of added value 
products in Pharmaceuticals, Food Supplements, Medical Devices, Cell therapies and 
Genetics (http://www.qualiapharma.com/). 
Given the presence at the sectors of pharmaceuticals and supplements Qualia has 
already suppliers at these sectors formulations, so that they will be the potential 
distributors at the beginning dissemination of astaxanthin. These suppliers from 
different European countries will be the firstly contact for the sale of astaxanthin as a 
raw material with a range of industrial applications. 
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7. THE SCHEDULE 
 
The schedule of this work plan has been split up into six (6) work packages.  A short 
description of each work package follows below:  
❖ WP1- Magnetic algae preparation 
❖ WP2 - Magnetic cultivation of Algae 
❖ WP3 - Animal Food, Nutraceutical & Cosmetics from Algae 
❖ WP4 –Operation and Assessment 
❖ WP5 – Exploitation and Business Development 
❖ WP6 – Project Management & Dissemination 
 
Chart 8, (Appendix C: Gantt chart) is a Gantt chart showing the project ‘s timeline. 
Management and disseminations actions are grouped within WP6 while exploitation 
activities are considered within WP5. The WP1, WP2, WP3, WP4 deal with 
interconnected scientific and technological activities in order to demonstrate the 
system. 
The completion of the project is calculated at the end of March of 2020. Then Qualia 
will find distributors and will start the dissemination and selling of astaxanthin to their 
future potential distributors globally. According to this state we begin our assumptions 
at our estimations of funding’s and revenues from the 2020, see § Funding’s and 
Revenues. 
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8. FUNDINGS AND REVENUES 
8.1 Market estimation 
As we referred at the sector of Business Model, Qualia S.A. main concern will be to 
find distributors to sell the astaxanthin as raw material, in bulking. In order to calculated 
estimated earnings, we are depended on some assumptions.  
Firstly, owing to high price of natural astaxanthin, global consumption regions are 
mainly distributed in Europe, North America and China. In 2017, North America 
consumed about 25724 Kg. Followed by Europe, with a consumption amount of 15032 
Kg (Market Watch, 2019). These data give us the base facts to forecast the market for 
the first five years of the new raw material product presence. The business model 
refers to 3 segments markets which is Europe, North America and the Rest of the 
World. 
Also, according to Research Reports Inc. (2018), from 2013 to 2017, global natural 
astaxanthin production increased with an average increase rate of 11.23%, we 
suppose that we will have the same average increase rate in consumption of global 
natural astaxanthin. Based on these figurative, we are relied to calculate the market 
as presented in the following table. 
Table 17: Market of natural astaxanthin in kilos by region  
Region (kg) 2020 2021 2022 2023 2024 
Europe 20.685 23.007 25.590 28.463 31.659 
North America 35.398 39.373 43.794 48.712 54.182 
Rest of the World 20.217 22.487 25.012 27.820 30.944 
Total 76.300 84.867 94.396 104.995 116.785 
 
8.2 Market Share 
Based on our competitive advantage which has to do with the final cost of astaxanthin 
as a raw material, we expect to gain a fairly market share of distributors, particular from 
5% - 40% depending on the market as presented in the following table. We suppose 
that in the first three years there will be an upward increase in market share because 
we will be more competitive with our price and we expect to reach double rising of the 
market share between 2022 and 2023, then a more conservative increase of 5% per 
year. 
At the first two years we are aimed to find distributors in Europe. Afterwards, at the 3rd 
year in North America and 4rd and 5rd year at the Rest of the World. In addition, we 
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are developed at 2 scenarios Business Plan (Normal Case, and Worst case) in order 
to analyse all possibilities and asses the viability of this concept. 
    Table 18: Normal Scenario - Market share of natural astaxanthin with the technology Valuemag  
Normal Case 
Scenario2  2020 2021 2022 2023 2024 
Europe 5% 15% 30% 35% 40% 
North America   5% 15% 30% 
Rest of the World       5% 15% 
 
     Table 19: Worst Scenario - Market share of natural astaxanthin with the technology Valuemag 
Worst Case 
Scenario3 2020 2021 2022 2023 2024 
Europe 3% 5% 7% 10% 12% 
North America   3% 5% 7% 
Rest of the World       3% 5% 
 
8.3 Pricing 
There is a wide range in the pricing of natural astaxanthin and it depends of the 
cultivation method and the extraction techniques. Due to the absence of data about 
the current market prices of natural astaxanthin per kilos across countries either the 
rate of reduction of astaxanthin price, we depend on different content/composition 
of astaxanthin (1%, 5%, 10% and 97%) and their price that exist at the current market 
globally, see Table 19. Our technology offering an efficient and a cost-effective way of 
the production and selling of astaxanthin as a result on this case of a fast market 
penetration strategy, the price should be lower from the current one by common 
cultivation techniques (such as open ponds, horizontal tubular photobioreactors and 
flat panel photobioreactors).     
In this case, based on the assumption that the innovative cultivation method proposed 
by VALUEMAG consortium will allow to further reduce the cost (~30%) of biomass 
production with respect the tubular or flat panel photobioreactors, as shown following. 
A floor price can be set by content of astaxanthin meeting the above criteria, as shown 
in the next table.   
                                                          
2 Normal Case Scenario: Astaxanthin as a raw material producing from innovative Valuemag 
magnetic technique achieved the acceptance from the distributors. 
3 Worst Case Scenario: penetration of other distributors with a cost-effective way and with 
highest purity of astaxanthin or we failed to find distributors and let them know our innovative 
technology 
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 Table 20: Current market price of astaxanthin and expected price with proposed magnetic cultivation. 
Current Market Prices Proposed Price with Valuemag Technology 
Content % of 
Astaxanthin 
Price/kg (€)  
Content % of 
Astaxanthin 
Price/kg (€)  
1% 90 1% 63 
5% 675 5% 472,5 
10% 1.125 10% 787,5 
97% 2.560 97% 1.792 
 
8.4 Profit and Loss forecast 
Based on the expected market share of distributors in the normal and worst scenario 
it is calculated with the number of consumptions in kilos in each region and are 
multiplied by the proposed price with Valuemag technology. Also, we analyse two 
options of them, in a low content (5%) and a high (97%) of astaxanthin.  
The following is the projected Profit and Loss table. 
Revenues (Euro) = Consumption/ Demand X Market Share X Proposed Price  
Table 21: astaxanthin with content 5%, normal scenario and worst scenario 
Normal Case Scenario 
Market (pοwder 
specification 5%)  Year 1  Year 2  Year 3  Year 4  Year 5  
Europe 488.683 1.630.621 3.627.382 4.707.068 5.983.551 
North America 0 0 1.034.633 3.452.463 7.680.298 
Rest of the World 0 0 0 657.247 2.193.156 
Total 488.683 1.630.621 4.662.015 8.816.778 15.857.005 
Worst Case Scenario 
Market (pοwder 
specification 5%)  Year 1  Year 2  Year 3  Year 4  Year 5  
Europe 293.209 543.54 846.389 1.344.876 1.795.065 
North America 0 0 620.779 1.150.821 1.792.069 
Rest of the World 0 0 0 394.348 731.052 
Total 293.209 543.54 1.467.168 2.890.045 4.318.186 
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Table 22: astaxanthin with content 97%, normal scenario and worst scenario 
Normal Case Scenario 
Market (pοwder 
specification 97%)  Year 1  Year 2  Year 3  Year 4  Year 5  
Europe 1.853.376 6.184.281 13.757.184 17.851.993 22.693.171 
North America 0 0 3.923.942 13.093.785 29.128.243 
Rest of the World 0 0 0 2.492.672 8.317.747 
Total 1.853.376 6.184.281 17.681.126 33.438.450 60.139.161 
Worst Case Scenario 
Market (pοwder 
specification 97%)  Year 1  Year 2  Year 3  Year 4  Year 5  
Europe 1.112.025 2.061.427 3.210.009 5.100.569 6.807.951 
North America 0 0 2.354.365 4.364.595 6.796.590 
Rest of the World 0 0 0 1.495.603 2.772.582 
Total 1.112.025 2.061.427 5.564.374 10.960.767 16.377.123 
 
The following is the projected Profit and Loss table containing the total production costs 
and total operating costs including also increased promotional and administration cost, 
see Table 23 Appendix D: Profit and Loss forecast. Cost of Goods which represents 
the cost of raw material, packaging and manufacturing can be further decrease as the 
quantities produced are higher. 
It is remarkable that the astaxanthin as raw material is profitable since the first year 
after launch, see Table 24, 25, 26, 27, 28 Appendix D: Profit and Loss forecast. A 
similar P&L analysis was performed for the Normal and Worst scenario for the two 
options in composition of astaxanthin, low (5%) and high (97%). Even in the worst-
case scenario the business remains profitable. 
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9. CONCLUSION - DISCUSSION 
One of the major drawbacks in microalgae production systems is the high costs of 
cultivation, harvesting and infrastructure. Moreover, the exploitation and dissemination 
of abundant bioactive secondary metabolites that can be extracted from microalgae 
should be faced.  In order to overcome these obstacles for the viability of microalgae, 
additional advances are necessary to develop economic and efficient microalgae 
production systems for the feasible exploitation of their bioactive molecules.  
The present study was aimed at presenting the innovative Valuemag project. This 
project was based on these facts and in the gap, which exists in the algae production 
and cultivation systems at the current market. In more details, VALUEMAG project 
scope to provide revolutionary solutions for microalgae production and harvesting as 
well as scaling up exploitation of algae valuable extracted compounds. Production, 
cultivation and harvesting objectives are achieved by using magnetic 
nanotechnologies as a result these innovations permit optimum cultivation, enhance 
biomass productivity and dramatically lower costs of biomass production. Biomass and 
extracted bioactive compounds from microalgae are directly utilized by VALUEMAG 
multi-facilities bio-refinery for the production molecules in a wide range of industrial 
applications like pharmaceutical, nutraceuticals, food additives and cosmetics 
(https://www.valuemag.eu/).  
After research of some bioactive compounds that can be extracted from microalgae, 
carotenoids and more specifically astaxanthin present considerable interest in 
comparison with the other extracted compounds. Astaxanthin, a xanthophyll 
carotenoid, is a secondary metabolite synthesized by a number of natural sources 
(bacteria, microalgae, yeasts and others) or synthetic sources and is represent a 
valuable compound with wide range of industrial applications. There are several 
microalgae strains that are suggested as potential sources to produce astaxanthin. 
Among them H. pluvialis can accumulate the maximum content of this antioxidant 
compound in stressfully environmental conditions. 
Since it is a compound with high nutritional value, strong demand at the global market, 
great potential in the market and high market value (2200–6200€/kg), in depth 
investigation of H. pluvialis efficient culture systems and production of added value 
final products are highly required for further development of this sector. Therefore, 
Valuemag design to overcome all of these barriers. Its purpose is to develop a natural 
raw material of astaxanthin with an efficient way; and with the feasible recovery and 
purity of this pigment from the strain Haematococcus pluvialis. Due to the innovative 
technology that proposed and that astaxanthin will offer a variety of applications in 
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pharma, cosmetics, foods and beverages, it was considered to be a fairly competitive 
raw material compared to the existing ones. That is why it was necessary to assess 
what its prospect will be in the global market and a feasibility study was done. 
Firstly, a market analysis was carried out on the global algae market further at global 
carotenoids market and finally at global natural astaxanthin market.  It was found to be 
highly developed with many prospects based on studies showing an increase in 
CAGR% over the coming years. However, following an investigation into existing 
competition, it has been found that due to the disadvantages of existing cultivation and 
exploitation methods of algae, the magnetic cultivation system of Valuemag is able to 
fill the gap in the market globally. In addition, when it comes to target market, 
distribution channels and promotion, some suggested actions have been mentioned. 
Subsequently, the cost of production of the proposed method was calculated, including 
staff expenses, operating costs, techniques and raw material costs. Certain 
assumptions were made to it is possible to calculate the necessary funding’s and the 
expected inflows and outflows that the company will expect in each year. Taking into 
account all elements of the financial plan, it is estimated that the company will present 
profitability from the first year of production either in the normal scenario (astaxanthin 
achieved the acceptance from the distributors) either at the worst scenario (penetration 
of others distributors or failure to find distributors and dissemination of the innovative 
magnetic technology). As the project has not yet been finished, we are not be able 
absolute sure about these final estimations at funding’s and revenues. 
In conclusion, the incredible potential of microalgae could make significant possibilities 
in the industrial world in the forthcoming years. Natural astaxanthin production which 
derived by the strain of Haematococcus pluvialis is an appealing option from a 
business point of view with competitive advantage in comparison to the synthetic 
astaxanthin with the proposed magnetic cultivation system of Valuemag. At the end, 
eventual domination of natural astaxanthin from the synthetic one will offer expansion 
in the applications in the pharmaceutical, nutraceuticals, food additives and cosmetics 
sector as well.   
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Table 2: List of participants (https://www.valuemag.eu/) 
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Table 3: Microalgae products (García et al., 2017). 
Products Microalgae 
 Food  Chlorella, Spirulina,Odontella auriata, Tetraselmis chuii Aphanizomenon flosaquae, Nostoc, A. 
sacrum, Spirogyra, Oedogonium 
 Feed Chlorella, Spirulina, Tetraselmis, Isochrysis, Pavlova, Phaeodactylum, Chaetoceros, Nannochloropsis, 
Skeletonema, Thalassiosira 
Vitamins & carotenoids  
 Vitamin B12 Chlorella, Spirulina 
 Vitamin E Porphyridum cruentum 
 β-carotene D. salina, Haematococcus pluvialis, Synechococcus, Nanocloropsis gaditana 
 α-carotene Chlorella 
 Astaxanthin D. salina, H. pluvialis, Chlorella 
 Lutein Murellopsis sp., Chlorella, Scenedesmus almeriensis, Auxenochlorella protothecoides 
 Zeaxanthin D. salina, Chlorella, Synechococcus, N. gaditana 
 Canthaxanthin Scenedesmus komarekii, D. salina, Chlorella 
 Fucoxanthin Phaeodactylum tricornutum 
 Phytoene D. salina 
 Phytofluene D. salina 
 Violaxanthin Chlorella, Synechococcus, N. gaditana 
 Antheraxanthin Chlorella 
 Echinenone Botrycoccus braunii 
 Cryptoxanthin D. salina 
Phycobiliproteins  
 Phycocyanin Spirulina 
 Phycoerythrin Porphyridium 
 Allophycocyanin Spirulina 
Chlorophyll  
 Chlorophyll A A. flosaquae 
PUFAs  
 Eicosatetraenoic acid (EPA) Phaeodactylum tricornutum, Monodus subterraneus, P. cruentum, Chaetoceros calcitrans, 
Nannochloropsis,Schizochytrium 
 Docosahexaenoic acid (DHA) Crypthecodinium cohnii, Isochrysis galbana, Pavlova salina, Schrizochytrium 
 Linoleic acid D. salina 
 y-linolenic acid Spirulina 
 Oleic acid D. salina, Spirulina 
 Lauric acid Spirulina 
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Polysaccharides  
 Sulphated polysaccharides Porphiridium spp. 
 Nostoflan Nostoc flagelliforme 
Sterols  
 Brassicasterol, sitosterol, and 
stigmasterol 
D. salina, Dunaliella tertiolecta 
Phenolic & volatile compoounds  
 Phenolic compounds Chlorella, Nostoc, Anabaena, Tolypothrix, Chlamydomonas 
 β-Cyclocitral D. salina 
 α- and β-lonone D. salina 
 Neophytadiene D. salina 
 Phytol D. salina 
 Pentadecane Synechocystis sp. 
 Heptadecane Spirulina 
Extracts  
 Total Chlorella, chlamydomonas 
 Lipids Nostoc, Ulkenia 
 Carotenoids Chlorella 
 
Table 4: Selected microalgae‐derived bioactive compounds: their sources and function (Islam et al., 2017). 
Bioactive compounds Microalga source Function 
Pigments Lutein Muriellopssis sp. 
Scenedesmus almeriensis 
Chlorella sp. 
Prevention of cancer, protection from 
macular degeneration and cognitive 
impairment 
 Astaxanthin Chlorella zofigiensis 
Dunaliella salina 
Haematococcus pluvialis 
Antioxidant and anti-inflammatory 
properties, effective against cancer, 
protein degradation, Parkinson’s 
disease, reduced vision, rheumatoid 
arthritis 
 β-carotene Nannochloropsis  
Gaditana 
Dumaliella salina 
Haematococcus pluvialis 
Prevention of breast cancer and 
macular degeneration 
PUFAs EPA Phaeodactylum 
Tricornutum 
Nannochloropsis sp. 
Monodus subterraneus 
Neural development, prevention of 
cardiovascular disease, lessen and 
protect against COPD, asthma, 
rheumatoid arthritis, atherosclerosis, 
Crohn’s disease and cystic fibrosis. 
 DHA Cryptheocodinium cohnii 
Pavlova salina 
Isochrysis galbana 
Facilitate child and infant 
development 
 Linolenic acid Dunaliella salina 
Spirulina platensis 
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Proteins Phycobiliproteins, 
Hormone-like 
bioactive peptides, 2-
20, and essential 
amino acids, etc. 
Haematococcus pluvialis 
Chlamydomonas 
Reinharditi 
Chlorella sp. Spirulina sp. Scenedesmus sp. 
Dunaliella sp. 
Oscillatoria sp. 
Chlamydomonas sp. 
Anticancer, immunomodulation, 
Hepatoprotective, anti-inflammatory, 
Antioxidant, antimicrobial properties, 
protection of DNA 
Production of recombinant proteins, 
e.g., for type 1 diabetes detection, 
etc. 
Vitamins Cobalamin (vitamin 
B12) 
Dunaliella tertiolecta 
Chlorella sp. 
Sprirulina sp. 
Antioxidant activities, role in body 
function, immunity, digestive system, 
etc. 
Tocopherols (vitamin 
E) 
Dunaliella tertiolecta 
Porphyridium cruentum 
Thiamin (vitamin B1) Tetraselmis suecica 
Nicotinic acid 
(vitamin B3) 
Tetraselmis suecica 
Ascorbic acid (vitamin 
C) 
Tetraselmis suecica 
Biotin (vitamin B7) Chlorella sp. 
Polysaccharides Sulfated 
polysaccharides 
Insoluble fiber and 
others 
Porphyridium sp. 
Spirulina platensis 
Phaeodactylum sp. 
Chlorella stigmatophora 
Gyrodinium impudicum 
Antiviral, antioxidant, antitumor, 
anti-inflammatory, 
antihyperlipidemic and anticoagulant 
activities 
Phenolic 
compounds 
Heptadecane, 
Tetradecane, etc. 
Nitzschia laevis Nostoc 
Ellipsosporum Nostoc 
Piscinale Chlorella 
Protothecoides 
Synechococcus sp. 
Chlorella Vulgaris 
Anabaena cylindrica 
Tolypothrix tenuis 
Chlorella pyrenoidosa 
Crypthecodinium cohnii 
Chlamydomonas nivalis 
Anticancer, antidiabetic action, 
lessen the risks of cardiovascular and 
neurodegenerative diseases, 
protection from biotic and abiotic 
stress 
Phytosterols Brassica sterol, 
sitosterol, 
stigmasterol, etc. 
Dunaliella tertilecta 
Dunaliella salina 
Cholesterol-lowering and 
neuromodulator activities, flights 
nervous system anomalies, 
autoimmune encephalomyelitis, 
amyotrophic lateral sclerosis 
 
 
Table 7: Human and animal health benefits of H. pluvialis-derived astaxanthin on various physiological systems (Shah 
et al., 2016). 
Physiological 
System 
Subject Effect followed Main outcome 
Anti-oxidation Rabbits Thioredoxin reductase; Paraoxonase acticity Enhanced; No effect 
Rats Hepatoprotective and antioxidant activity Improved 
Rats Antioxidant enzymes, catalase, superoxide dismutase, 
peroxidase, and lipid peroxidation in plasma and liver 
Increased 
Men (bilateral 
cataract) 
Antioxidative effects through changes in superoxide 
scavenging activity, and hydroperoxides production in 
aqueous humor 
Enhanced; Suppressed 
Eye function 18 healthy men Deep vision Improved 
10 healthy men Eye function Improved 
40 asthenopia 
patients 
Eye accommodation power Improved 
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49 healthy men Uncorrected far visual acuity Improved 
87 men (visual 
display terminal 
workers) 
Eye accommodation amplitude (the adjustment in the lens 
of the eye that allows it to focus); 
Improved 
Eye soreness, dryness, tiredness, and blurred vision Reduced 
Skin Healthy female or 
male 
Skin wrinkle, corneocyte layer, epidermis, and dermis Improved 
46 healthy women Skin elasticity and moisture Improved 
Immune 
response 
14 healthy women Oxidative stress and inflammation markers; Immune 
response 
Reduced; Improved 
Inflammation Rats Gastrointestinal health Improved 
Gastric ulcer H. pylori-infected 
mice 
Bacterial load Gastric inflamation Reduced 
 
Rats 
 
Gastir ulcer markers Reduced 
44 patients with 
functional 
dyspepsia 
Inflammatory markers; gastrointestinal discomfort No effect; No effect 
Cardiovascular 
system 
20 adult men Blood flow time Improved 
Men Blood plasma levels Reduced 
Muscle 
endurance 
16 non-trained 
men 
Lactic acid accumulation after run Reduced 
19 non-trained 
men 
Respiratory and sympathetic nervous system activities Improved 
20 non-trained 
men 
Strength/explosiveness tes; strength/endurance test No effect; Improved 
20 resistance-
trained men 
Markers of skeletal muscle injury No effect 
Cancer Rats Growth of colon cancer cells Inhibited 
Central nervous 
system  
Healthy mice Memory Improved 
10 healthy men 
(50-69 years) 
Response time and accuracy of several tasks Improved 
Middle 
aged/elderly men 
and women 
Cog Health battery scores (Nuropsychological memory test) Improved 
Male fertility 20 sub-fertile men Semen quality, pregnancy rate Improved 
30 sub-fertile men Sperm velocity; oxidation markers; Improved; Reduced 
Pregnancy rate Improved 
24 healthy men Idiopathic infertility Decreased 
Metabolic 
Syndrome (MS) 
Obese rats Body weight; adipose tissue weight; Reduced; Reduced 
MS markers Improved 
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Appendix A: Health benefits of Astaxanthin  
 
 1. Longevity 
▪ Rationale 
Appears to stimulate stem cell proliferation at a very low concentration relevant 
to oral supplementation  
▪ 1.2 Non-Mammalian Interventions 
Astaxanthin may be able to promote cellular longevity secondary to boosting 
antioxidant defences 
 2. Cardiovascular Health 
▪ 2.1 Blood pressure 
Astaxanthin is thought to promote blood flow in part secondary to its antioxidant 
properties 
▪ 2.2 Red blood cells 
6mg astaxanthin or higher appears to reduce membrane oxidation in red blood 
cells 
 3. Interactions with Glucose Metabolism 
 4. Obesity and Fat Mass 
▪ 4.1 Adipokines 
Increase adiponectin as a result the reductions in triglycerides and increase in   
HDL-C 
 5. Skeletal Muscle and Physical Performance 
 6. Inflammation and Immunology 
 7. Interactions with Oxidation 
▪ 7.1 Antioxidant Enzymes 
Can increase Nrf2 activity and antioxidant enzymes in retinal cells secondary to 
activating the PI3K/Akt pathway 
▪ 7.2 Lipid Peroxidation 
 Studies in overweight persons have noted significant improvements in general 
oxidation and the superoxide dismutase enzyme 
 8. Interactions with Hormone 
 9. Interactions with Organ Systems 
▪ 9.1 Eyes 
Appears to have general antioxidant properties in eye tissue 2. May increase 
ocular blood flow without any significant changes in ocular blood pressure 
measurements  
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▪ 9.2 Lungs 
Smokers appear to have less overall exposure to astaxanthin following oral 
supplementation 
• 10.Interactions with Aesthetics 
▪ 10.1 Skin 
Topical application or oral supplementation of astaxanthin appears to improve 
elasticity and symptoms of skin aging  
• 11. Sexuality and Pregnancy 
▪ 11.1 Menopausal Symptoms 
48% reduction in symptoms of menopausal symptoms ( https://examine.com/ ) 
 
Figure 6: Health benefits of Astaxanthin with Human Clinical Studies and Supporting Pre-Clinical 
Trials which represented from company Beijing Gingko Group Biological Technology Co. Ltd 
(BGG) (https://bggworld.com/) 
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Appendix B: Charts  
 
 
Chart 1: Represent the expected increase in the global algae products market (USD billion) according 
to the following reports in specific periods. Reports: Grand View Research (2017), Markets and Markets 
(2018) a, Markets and Markets (2018) b, Research and Markets (2018), Credence Research (2017), 
Research and Markets (2017), Markets and Markets (2018). 
 
Chart 2: Represent the expected increase in the global algae products market (GAGR %)4 according 
to the following reports in specific periods. Reports and forecast periods: Markets and Markets (2018-
2023), Research and Markets (2016-2023), Credence Research (2016-2023), Research and Markets 
(2017-2022), Grand View Research (2018-2025) 
From Chart 1 we can draw the result that global algae products market will be flat from 
2015 to 2018. Afterward until 2022 it will suffer from a slightly decrease and on 2023 
and forward, we are going to have a boom with a noticeable increase. For the both of 
the charts, the outcomes show business fluctuations due to that the presented results 
have been collected from various market research. 
                                                          
4 GAGR %: Compound Annual Growth Rate 
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Chart 3: Represent the expected increase in the global carotenoids market (USD billion) according to 
the following reports in specific periods. Reports: Grand View Research (2016), Markets and Markets 
(2016), Research and Markets (2016), Markets and Markets (2016), Global Industry Analysts, Inc, 
Research and Markets (2017) a, Research and Markets (2017) b. 
 
 
Chart 4: Represent the expected increase in the global carotenoids market (GAGR %)5 according to 
the following reports in specific periods. Reports and forecast periods: Research and Markets 2017 
{(2016-2025), (2017)2027)}, Markets and Markets 2016 (2016-2021), Research and Markets 2016 (2016-
2021).  
According to various market studies and research we notice that the global market of 
carotenoids, will be remain in a stably rate with a slight increase from 2015 to 2025 
and with annual compound growth rate 4.2%. 
                                                          
5 GAGR %: Compound Annual Growth Rate 
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Chart 5: Represent the expected increase in the global astaxanthin market (USD billion) according to 
the following reports in specific periods. Reports: Research and Markets (2015)/ Industry Experts (2015), 
Grand View Research (2017), Research and Markets (2017), Global Market Insights (2018), PRNewswire 
(2017), Research and Markets (2015)/ Industry Experts (2015), PRNewswire (2017), Research and 
Markets (2017), Wise Guy Research Consultants Pvt. Ltd. (2018), Grand View Research (2017). 
 
Chart 6: Represent the expected increase in the natural global astaxanthin market (USD billion) 
according to the following reports in specific periods. Reports: Market Reports World (2017)/ Market 
Update (2018), Research and Markets (2018). 
According to Chart 5, the global astaxanthin market have differentiation of the total size 
which is expected to reach from 2014 to 2023. At 2025 is predicted to reach the highest 
size, approximately double increase of the total market size since the forecast period 
2017- 2025 from 2015 – 2018 (Veracious Statistics Research, 2018). Concerning to 
natural global Astaxanthin Market there is a remarkable increase from 2013 to 2024 
with Annual Growth Rate reaching approximately 7.5%. Also, the outcomes show 
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business fluctuations due to that the presented results have been collected from 
various market research. 
 
Chart 7: Represent the expected increase in the global algae astaxanthin market (GAGR %)6 
according to the following reports in specific periods. Reports and forecast periods: Prnewswire, 
(2017){(2017-2022)}, Global Market Insights (2018){(2018-2024)}, Gos Reports, (2016){(2016-2020)}, 
Research and Markets (2017){(2016-2023)} 
                                                          
6 GAGR %: Compound Annual Growth Rate 
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Appendix B: Leading market participants in the industry of algae  
 
The key players operating in the global algae products market are DIC Corporation 
(Japan), Cellana Inc. (U.S.), Taiwan Chlorella Manufacturing Company (China), 
Algaetech International Sdn Bhd (Malaysia), Cyanotech Corporation (U.S.), Blue 
BioTech Int. GmbH (Germany), Algatechologies ltd. (Israel), Pond Technologies Inc. 
(Canada), E.I.D. - Parry (India) Limited (India), Tianjin Norland Biotech co., ltd., 
(China), AlgaeCan Biotech Ltd. (Canada), Corbion NV (The Netherlands), Qponics 
Limited (Australia), Royal DSM (The Netherlands), Heliae Development, LLC (U.S.), 
and Sun Chlorella Corporation (Japan (Research and Markets, 2018) 
Appendix B: Key players in the carotenoids market  
 
include BASF SE (Germany), Royal DSM N.V. (The Netherlands), Chr. Hansen A/S 
(Denmark), FMC Corporation (U.S.), Kemin Industries, Inc. (U.S.), and Cyanotech 
Corporation (U.S.) (http://www.algaeindustrymagazine.com/). Other companies that 
have a strong presence in the carotenoids market contain D.D. Williamson & Co., Inc. 
(U.S.) Allied Biotech Corporation (Taiwan), ExcelVite Sdn. Bhd. (Malaysia), and Döhler 
Group (Germany) (Markets and Markets, 2016). 
Appendix B: Key players of the market of astaxanthin 
 
Some major players of this market are Algatechnologies; Cyanotech Corporation; Fuji 
Chemical Industry Co., Ltd.; BlueOcean NutraSciences, Inc.; MicroA AS; Fenchem; 
EID-Parry (India) Ltd.; Beijing Gingko Group (BGG); Heliae Development, LLC; IGENE 
Biotechnology, Inc.; and JX Nippon Oil and Energy Corporation. They are highly 
focused on new product development, mergers & acquisitions, and expansion to 
untargeted geographies in order to enhance their market position.  
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Appendix C: Competition 
 
Table 12: Leading commercial companies and their H. pluvialis-deriver astaxanthin. 
 
 
 
 
Culture System Company Name Country/ Location Brand Name/ Marketed product Forms Product particulars/ Application area B2B B2C
BioAstin® (extract)
Super Critical Extract 5% 
(SCE5) Oil
Astaxanthin extract packaged in soft gel, 
beadlets; dietary supplement
Naturose™ (powder)
 Spray dried and 
formulated into a fine 
dark red powder
 Algae meal; pigmentation source for 
ornamental fish and animals
Parry Nutraceuticals Ltd. India Zanthin®
Astaxanthin oleoresins, beadlets, and 
soft gel
- √
Valensa International 
(subsidiary of Parry 
Nutraceuticals Ltd.)
USA Zanthin® Astaxanthin extract, soft gel, beadlets - √
Astaxathin powder              
(1.5-3.0%) 
Dry algal biomass; Food and Feed Grade 
 (5-10%) Natural 
Astaxanthin oleoresin 
astaxanthin soft gel; Nutraceutical, 
Cosmetics and Food products
Supreme Asta Oil™
Oleoresin, 5% and 10% 
standardized content of 
Astaxanthin complex
oleoresin for food, beverage dietary 
supplements and cosmetic products
Beadlets, free flowing 
powder, 2% and 2,5% 
standardized content of 
Astaxanthin complex
for applications in tablets and hard 
capsules
 red meal oil, 1.5% feed supplement/ feed grade
Heliae Development LLC USA  TruAzta™ 10% astaxanthin oleoresin
nutraceutical supplements, food 
products, cosmetics, and aquaculture
√ √
Haematococcus Cracked 
Dried Powder
Algae biomass (feed supplement)
Astaxanthin Oleoresin        
( 2.4% – 5.0%)
oleoresin (Nutraceutical industry, 
Cosmetics Industry and Food products),
Astaxanthin Capsule            
(2.5% – 5.0% Oleoresin)
soft gel
AstaFactor® (algae meal extract)
Astaxanthin packaged as soft gel; dietary 
supplement, human nutraceutical 
AquaXan®  pigment for shrimp and salmon feed
Mera Pharmaceuticals Inc. USA √ -
-
 Supreme Asta powder™
Algaetech International SDN 
BHD 
Malaysia Astaxanthin Premia-Ex √ √
Atacama Bio Natural 
Products S.A. 
Chile √
Jingzhou Natural Astaxanthin 
Inc.
China NaturAsta™ √ -
1. Closed PBRs 
Combined with 
Raceway Ponds
Cyanotech Corporation USA √√
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Culture System Company Name Country/ Location Brand Name/ Marketed product Forms Product particulars/ Application area B2B B2C
5%, 10%, 20% oleoresin
in soft gel capsules and oil based 
products such as topical creams and 
emulsions
2.5% Astaxanthin beadlets 
2% Astaxanthin vegeterian 
beadlets
for tablets and hard-shell capsules 
4mg, 12mg Astaxanthin 
Vegeterian Softgels
ready softgels supplied in bulk 
2% Astaxanthin CWS 
powder 
for liquid supplements, sachet,  stick 
pack, gummples and more
AstaPure™ ARAVA
4mg Bulk Astaxanthin 
Whole Algae Tablets
Dry algal biomass, astaxanthin beadlets, 
and oleoresin
5%, 10%, 20% astaxanthin 
oleoresin
Softgel capsules; cosmetics
Astaxanthin Water 
Dirspesible Powder 1%, 2%
hard capsules; drinks, sachets
Astaxanthin Water 
Dirspesible Emulsion 1%
for drinks and cosmetics
Astaxanthin fish gelatin 
Beadlets 2%, 2.5%
tablets, hard capsules
Astaxanthin Veggie 
Beadlets 3%
tablets, hard capsules
Astaxanthin Spray Dried 
Powder 4%, 5%
tablets, hard capsules and softgel 
capsules 
2% Astaxanthin Powder, 
2% CWS powder water 
soluble
Powder
2.5%, 3%, 3.5% Natural 
astaxanthin biomass
 Biomass
 5%, 10% astaxanthin 
oleoresin
Oleoresin
√ √
Yunnan Alphy Biotech Co., 
Ltd.
China Alphy™ √ -
√ -
Beijing Gingko Group 
Biological Technology Co. Ltd 
(BGG) / Algae Health 
Sciences, Inc.,
China AstaZine®
2. Closed Tubular 
Photo-bioreactors
Algatechnologies Ltd. Israel
AstaPure™
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Culture System Company Name Country/ Location Brand Name/ Marketed product Forms Product particulars/ Application area B2B B2C
Oil Extract
For softgel capsules, cosmetic 
applications
Powder For hard capsules, tablets
Watersoluble
For beverages, liquid nutraceuticals 
supplements
Beadlets
For dietary supplements in powder 
sachets
Biomass For hard capsules, tablets
Softgel Capsules Ready-made soft capsules
Algae to Omega Holdings, 
Inc.
USA AstaMatrix® Dietary Supplement - √
4. Closed Plastic Bag 
Photo-bioreactors
Supreme Health New 
Zealand Ltd.
New Zealand AstaNZ™/ ASTAS™
Supplements, Cosmetics; Age Defined 
Skincare, Capsules; Edurance and 
Recovery
- √
5. Closed Flat Panel 
Photo-bioreactors
Fraunhofer IGB & Subitec 
GmbH                         
(independent research unit)
Germany 
human dietary supplement 
containing Astacarox/ feed 
supplement for horses /feed 
supplement for animals
*provide the scientific know-how to 
produce large quantities of 
Haematococcus algae biomass with a 
high astaxanthin content.
- -
AstaXine® AstaCaroxe® (crashed 
powder) 
Natural Astaxanthin 
Oleoresin 
(Haematococcus Extract)
Dietary supplement containing algae 
crushed, and dried algae meal
 AstaEquus®
Natural Astaxanthin 
Softgel
Astaxanthin extract feed supplement for 
horses
Novaasta® (powder)
Haematococcus Algae 
Biomass (Cracked)
Astaxanthin extract feed supplement for 
animals
Natural Astaxanthin 
Oleoresin 
(Haematococcus Extract)
Natural Astaxanthin 
Softgel
Haematococcus Algae 
Biomass (Cracked)
1.5%, 2%, 2.5%, 3%, 3.5%, 
4% Astaxanthin Powder
Food and Feed
Astaxanthin oleoresin         
(3%, 5%, 7%, 10%)
Food supplements (ideal for manufacting 
softgel) and cosmetics
Astaxanthin soft gels
Functional beverages and cosmetic 
applications
enacapsulated astaxanthin 
(1% and 2%)/ OEM
hard and soft capsules
n.a. Stazen Inc. USA Stazen®
Dietary supplement containing algae 
crushed and dried algae meal
- √
√ -
n.s.
Wefirst Biotechnology Co. 
Ltd. 
China AstaFirst™ √ -
Kunming Biogenic Co. Ltd. China AstaBio®
Algal biomass, oleoresins, beadlets, and 
soft gels of Astaxanthin
6. Indoor/ enclosed 
PBR
BioReaI (Sweden) AB 
(subsidiary of Fuji Chemical)
Sweden √ √
√
3. Closed 
Tank/Cylinder Photo-
bioreactors
Fuji Chemical Industry Co., 
Ltd (AstaReal Co., Ltd)
Japan, Sweden, USA
AstaREAL® (Supercritical CO2 
extracted oil)/ AstaTROL®
√
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Appendix C: Swot Analysis 
 
 
 Strengths Weaknesses 
In
te
rn
al
 
• Significant decrease of the cost of natural astaxanthin 
production  
• Ability to produce high quality and valuable raw 
material using in cosmetics, food and nutraceuticals 
• Sustainable ways of water cleaning and CO2 capture 
• Production-cultivation and harvesting objectives are 
achieved by using magnetic nanotechnologies, an 
innovation with competitive advantage 
• Astaxanthin, with powerful antioxidant properties, 
proved to have benefits on various health conditions 
including inflammation, diabetics, cardiovascular, 
vision and CNS conditions. 
• Astaxanthin has a wide range of applications in the food, 
feed, cosmetic, aquaculture, nutraceutical, and 
pharmaceutical industries 
• Haematococcus pluvialis, a freshwater microalga, was 
found out containing the highest level of astaxanthin 
 
• The need of a new production infrastructure 
• The first project applying this concept, 
despite of the number of publications and 
papers already available 
• Requires specialized and trained staff 
 
 Opportunities Threats 
E
x
te
rn
al
 
• Easy penetration in the astaxanthin production market  
• The need of clean water in many areas of the planet, 
together with the necessity for CO2 footprint reduction 
• A new technology of astaxanthin cultivation will be 
provided to European industries along with a new 
integrated biorefinery concept 
• Use of the technology for other bioactive compounds 
• Expected increase of demand for natural astaxanthin to 
produce high quality pharmaceutical molecules, 
nutraceuticals, food additives and cosmetics, open new 
markets in different directions 
• Exploitation and research & development for new 
utilizations or incorporated in already existing lines of 
products 
• Economic crisis that affects Greece as well as 
other European countries and globally 
• Distributors may affect final price 
• High competition level from synthetic 
astaxanthin  
• High competition from top players/ leaders in 
the bulking of astaxanthin with long-term 
presence in the global market  
• Probability imitation of VALUEMAG method 
or new producing technology from other 
technology competitors and penetration to the 
market* 
 
 
* Worldwide, research and demonstration programmes are being carried out to 
develop the technology needed to expand algae biomass production and exploitation. 
In the following, we mention some of the most relevant projects concerning the 
VALUEMAG project (Table 16):  
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Table 16: Worldwide projects, new technologies of production and exploitation of algae. 
 
Appendix C: Gannt Chart
Project Title Area
Biofuel from Algae Technologies BIOFAT
Sustainable Fuels from Marine Biomass Project - BIOMARA
Bio-waste and Algae Knowledge for the Production of 2nd Generation Biofuels BIOWALK4BIOFUELS
Energetic Algae ENALGAE
Utilisation of Micro-algae for Wastewater Treatment with Energy Purposes- ENERBIOALGAE
Marine Algae as Biomass for Biofuels MABFUEL
Biotechnological Exploitation of Marine Products and By Products BIOTECMAR
Control of Light Use Efficiency in Plants and Algae from Light to Harvest HARVEST
Towards a Better Sunlight to Biomass Conversion Efficiency in Micro-algae SUNBIOPATH
Enabling European SMEs to Remediate Wastes, Reduce GHG Emissions and Produce Biofuels via Micro-
algae Cultivation
BIOALGAESORB
Development of an algal platform for production of building blocks for the chemical industry and their 
further conversion to products 
SPLASH 
A sustainable chain for continuous biofuel production using micro- algae as a production platform, 
thereby making 2nd generation biofuels competitive alternatives to fossil fuels. 
Fuel4Me 
Demonstration of integrated and sustainable enclosed raceway and photobioreactor micro-algae 
cultivation with biodiesel production and validation. 
INTESUSAL 
Pilot scale algal research centre (including lipid production) Relevant to Biology & Biotechnology, 
Economic assessment 
ALGAEPARC 
Novel algae-based solution for CO2 capture and biomass production ALGADISK 
Genetic Improvement of Algae for Value Added Products GIAVAP 
Sustainable Production of Biologically Active Molecules of Marine Based Origin BAMMBO 
Oil production with algae Emerald Oils 
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   Chart 8: Cantt Chart 
  
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36
Task 6.7. Open Workshop
WPS
YEAR 1 YEAR 2 YEAR 3 
Task 6.1. Project coordination
Task 6.2. Financial and administrative management
Task 6.3. Dissemination plan
Task 6.4. Project website and Media relations
Task 6.5. Communications marketing material & Newletters
Task 6.6. Events Participation & Social Media
WP5: Exploitation and Business Development
Task 5.1. Market and socio-economic impact analysis
Task 5.2. Stakeholders Analysis and Exploitation Plan
Task 5.3. Market Penetration
Task 5.4. Develop Business Plan
WP6: Project Management & Results Dissemination
Task 4.1. Operation
Task 4.2. Modelling and simulation of the overall process
Task 4.3. Technical and economic assesment
Task 4.4. Energy systems analysis
Task 4.5. LCA assesment
Task 4.6. Assesment of regulatory and policy framework
Task 3.3. CO2-SF experimental test for microlagae and optimization tests
Task 3.4. CO2 SF experimental test for microalgae on pilot scale
Task 3.5. Selective Magnetic Separation of natural compounds
Task 3.6. Process modelling and design
Task 3.7. Risk analysis and Safety control
WP4: Operation and Assesment
Task 2.4. Selection of the most suitable methods for CO2 capture and water recovering
Task 2.5. System integration
Task 2.6. System functionalization and initial operation
WP3. Animal Food, Nutraceutical & Cosmetics from Algae
Task 3.1. Characterization of microlagae for bio-products
Task 3.2. Evaluated pre and post harvest of microlagae extract against plant pathogenic fungi
WP1. Magnetic algae preparation
Task 1.1. System for the magnetic nanoparticle development
Task 1.2. Uptake system of magnetic nanoparticles by algal cells
Task 1.3. Determination of parameters of uptake of magnetic nanoparticles from algal cells
WP2. Magnetic algae cultivation system
Task 2.1. Green-house development
Task 2.2. Development of SOMAC
Task 2.3. Development of the algal cell de-watering system
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Appendix D: Profit and Loss forecast 
  Table 23: Equipment and operating expenses for the production astaxanthin with the technology of Valuemag 
for the first five years.  
Equipment Costs and Operating Expenses 
Annual Expenses (€) 
Costs (€)  
Year 1 Year 2 Year 3 Year 4 Year 5 
Staff expenses 18000 18.000 19.800 21.780 23.958 
Operational Costs      
Energy/ Cultivating water 7.000 7.000 7.000 7.000 7.000 
Cleaning  5.000 5.000 5.000 5.000 5.000 
Machinery maintenance 10.000 10.000 12.000 12.000 12.000 
Promotion and Marketing 10.000 10.000 13.000 13.000 16.900 
Packaging Costs 10.000 10000 12.000 12.000 14.400 
Other unpredicted expenses 5.000 5.000 5.000 5.000 5.000 
Storage 2.000 2.000 3.000 3.000 4.000 
Rent and building expenses 10000 10000 10000 10000 10000 
Total  80.000 80.000 86.800 88.780 98.258 
Pre-treatment, Extraction, Drying and 
Quantification, Purification, Separation 75.000 82.500 90.750 99.825 109.807 
 
Table 24: P&L and Basic ratios – Normal Scenario (low content of Astaxanthin) 
 Year 1  Year 2  Year 3  Year 4  Year 5  
Sales 488.683 1.630.621 4.662.015 8.816.778 15.857.005 
Cost of Goods (~15%)  73.302 244.593 699.302 1.322.516 2.378.550 
GP (~ 85%)  415.381 1.386.028 3.962.713 7.494.262 13.478.455 
      
OPEX  260.381 1.223.528 3.785.163 7.305.657 13.270.390 
      
EBITA (~ 30%)  182.266 856.469 2.649.614 5.113.959 9.289.273 
      
Taxes (~ 25%)  45.566 214.117 662.403 1.278.490 2.322.318 
      
Net Profit  136.700 642.352 1.987.211 3.835.469 6.966.955 
 
Table 25: P&L and Basic ratios – Worst Scenario (low content of Astaxanthin) 
 Year 1  Year 2  Year 3  Year 4  Year 5  
Sales 293.209 543.54 1.467.168 2.890.045 4.318.186 
Cost of Goods 
(~15%)  43.981 81.531 220.075 447.006 647.727 
GP (~85%)  249.228 462.009 1.247.093 2.443.039 3.670.459 
OPEX  94.228 464.509 1.069.543 2.254.434 3.462.394 
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EBITA (~30%)  65.959 325.156 748.680 1.578.103 2.423.675 
Taxes (~25%)  16.489 81.289 187.170 394.525 605.918 
Net Profit  49.470 243.867 561.510 1.183.577 1.817.757 
 
Table 26: P&L and Basic ratios – Normal Scenario (high content of Astaxanthin) 
 Year 1  Year 2  Year 3  Year 4  Year 5  
Sales 1.853.376 6.184.281 17.681.126 33.438.450 60.139.161 
Cost of Goods (~15%)  278.006 927.642 2.652.168 5.015.767 9.020.874 
GP (~ 85%)  1.575.370 5.256.639 15.028.958 28.422.683 51.118.287 
      
OPEX  1.420.370 5.094.139 14.851.408 28.234.078 50.910.222 
      
EBITA (~ 30%)  994.259 3.565.897 10.395.985 19.763.854 35.637.155 
      
Taxes (~ 25%)  248.564 891.474 2.598.996 4.940.963 8.909.288 
      
Net Profit  745.694 2.674.422 7.796.988 14.732.890 26.727.866 
 
Table 27: P&L and Basic ratios – Worst Scenario (high content of Astaxanthin) 
 Year 1  Year 2  Year 3  Year 4  Year 5  
Sales 1.112.025 2.061.427 5.564.374 10.960.767 16.377.123 
Cost of Goods 
(~15%)  166.803 309.241 834.656 1.644.115 2.456.568 
GP (~85%)  945.222 1.752.186 4.729.718 9.316.652 13.920.555 
OPEX  790.222 1.589.686 4.552.168 9.128.047 13.712.490 
EBITA (~30%)  553.155 1.112.780 3.186.517 6.389.632 9.598.743 
Taxes (~25%)  138.288 278.195 796.629 1.597.408 2.399.685 
Net Profit  414.866 834.584 2.389.887 4.792.223 7.199.057 
 
Table 28: Sales & EBITA for the 2 Scenarios,  
SALES (€)  Year 1  Year 2  Year 3  Year 4  Year 5  
Normal 136.700 642.352 1.987.211 3.835.469 6.966.955 
Worst 49.470   243.867  561.510  1.183.577  1.817.757 
EBITA (€)  Year 1  Year 2  Year 3  Year 4  Year 5  
Normal 745.694 2.674.422 7.796.988 14.732.890 26.727.866 
Worst 414.866   834.584  2.389.887  4.792.223  7.199.057 
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Appendix E: Company Profiles 
COMPANY PROFILES7 
Cyanotech (https://www.cyanotech.com/) 
Company Overview 
As a world leader in the production of high value natural products derived from microalgae 
Cyanotech Corporation has been guided by the principle of providing high quality microalgae 
products for health and nutrition in a sustainable, reliable, and environmentally sensitive 
operation. Cyanotech Corporation, a world leader in microalgae technology for over 30 years, 
produces BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica®.  
They are third party certified to GMP (Good Manufacturing Practices) for dietary supplements, 
reinforcing their commitment to quality in their products, quality in their relationships (with their 
customers, suppliers, employees and the communities they live in), and quality of the 
environment in which they work. Their mission that guides their company is to "Fulfill the 
Promise of Whole Health Through Hawaiian Microalgae." 
All Cyanotech products are produced from microalgae grown at our 96-acre facility in Kona, 
Hawaii using patented and proprietary technology and are Generally Recognized as Safe 
(GRAS) for use in food products. Cyanotech sells its products direct to consumers at retail 
locations in the United States and online and distributes to dietary supplement, nutraceutical 
and cosmeceutical manufacturers and marketers. The Company is regulated by the FDA. 
1. Cyanotech Corporation Earns Non-GMO Project Verification for BULK SCE BioAstin 
Natural Astaxanthin Products 
2. Cyanotech Corporation Earns Halal Certification for BioAstin. Bulk raw material, 
BioAstin® SCE 5 and vegan BioAstin soft gels, have received halal certification from 
the Islamic Food and Nutrition Council of America (IFANCA). 
 
Method of cultivation of microalgae 
Cyanotech’s patented Ocean Chill DryingTM method allows the algae to dry in a chamber 
containing less than 1 percent oxygen in less than 7 seconds. This preserves the integrity of 
the antioxidant content. Furthermore, Cyanotech is one of the few companies in the world with 
the technology to accurately measure Natural Astaxathin levels. Cyanotech's methods have 
been accepted by the United States, Canadian, and Japanese governments. In 1999, 
BioAstin® was the first source of astaxanthin for human nutrition to be reviewed by the U.S. 
Food and Drug Administration (FDA). In fact, it passed review by the FDA and is now allowed 
to be sold in the US as a human dietary supplement. 
Product and End-User/ Application 
BioAstin® Hawaiian Astaxanthin® is a potent natural antioxidant that provides support for 
recovery after exercise, joint, skin, and eye health. BioAstin is derived from natural microalgae, 
Haematococcus pluvialis, that is cultivated, grown, and processed on the Kona coast of the Big 
Island of Hawaii. 
                                                          
7 All information has been collected from the official site and pages of every company 
separately. 
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BioAstin® is sold primarily as a packaged consumer product through Nutrex Hawaii to natural 
product distributors, retailers and online channels, or directly to consumers. It is also sold in 
liquid lipid form as a raw ingredient to dietary supplement manufacturers, health food 
formulators and cosmetic manufacturers. BioAstin® gelcaps are sold in bulk quantities to 
international distributors. 
Parry Nutraceuticals Ltd. (EID Parry) (http://www.parrynutraceuticals.com/) 
Company Overview 
Parry the world leader in micro algal technology. Certified for major International Food and 
Safety Standards, Parry Nutraceuticals products have charted constant growth in all its markets 
worldwide. Parry Nutraceuticals pioneered micro-algae cultivation in the market of dietary 
supplements and has been instrumental in bringing to the market algae-based products like 
Spirulina, Astaxanthin and Natural Mixed Carotenoids. Parry Nutraceuticals is the only 
company in the world to cultivate all three microalgae - Spirulina, Astaxanthin and Chlorella for 
human health. Headquartered in Chennai, India, they are a division of E.I.D. Parry (I) Ltd. and 
a part of the USD 4.3 billion Murugappa Group. 
Parry Nutraceuticals’ products have become an integral part of several major brands in more 
than 38 countries, the main markets being in North America, Europe, South East Asia and the 
Far East for many years now. 
Method of cultivation of microalgae 
Parry employs a unique, proprietary two-part process using all-natural Deep Extract® (high 
pressure) supercritical CO2 to create the highest quality extraction. They also utilize our O2B® 
Peroxidation Blocker stabilization technology to ensure long-term stability and efficacy for the 
consumer. This process uses no co-solvents or ethoxyquin obtaining the highest amount of 
active ingredients. 
Valensa, subsidiary of EID Parry (India) Ltd is the only producer of Astaxanthin in the United 
States. Valensa only uses extra virgin olive oil to standardize Astaxanthin. Valensa International 
is the first company to have finished form Astaxanthin material approved for use by regulatory 
agencies in both the United States (NDI – New Dietary Ingredient) and Europe (Novel Foods). 
Product and End-User/ Application 
Their astaxanthin begins with the microalgae Haematococcus pluvialis which is grown in a 
remote, pristine Chilean environment. The microalgae are extracted at their organic certified 
facility in Eustis, Florida using their proprietary Deep Extract® supercritical CO2 extraction 
process. Zanthin® Natural Astaxanthin is very clean and free from solvent residues. Zanthin® 
Natural Astaxanthin is also very stable. Valensa uses, all-natural O2B® peroxidation blocker to 
prevent degradation of astaxanthin during storage, encapsulation and packaging. O2B® 
peroxidation blocker provides Zanthin® Natural Astaxanthin with a superior four years of shelf 
life. These features combine to make Valensa’s Zanthin® the best astaxanthin on the market. 
Product offered in Oleoresin, Beadlets or Softgels. 
 
Jingzhou Natural Astaxanthin Inc.  
 
Company Overview 
Jingzhou Natural Astaxanthin Inc is a leading enterprise producing natural Astaxanthin by 
culturing Heamotococcus pluvialis in China, Asia. They were founded in 2003 to develop and 
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commercialize microalgae-derived products for the aquatic feed & human food industry.  Today, 
their company hold 32000㎡ culture area for Heamotococcus pluvialis. 
Product and End-User/ Application 
They can supply high-quality food grade and feed grade natural astaxathin powder (1.5 - 
3.0%) about 1.5 Ton/month, And 5-10% Natural Astaxanthin oleoresin content & Natural 
Astaxanthin softgel. 
NaturAstaTM Food Grade Haematococcus pluvialis Powder which is Natural esterified 
Astaxanthin complex in the form of Haematococcus pluvialis algae biomass, raw material for 
the extraction of a concentrated Astaxanthin complex. The Astaxanthin concentration of their 
algal powder is average 2.0 - 2.3% (20000-2300PPM). 
NaturAsta™ 5% astaxanthin oleoresin is a natural astaxanthin complex extracted from 
Haematococcus pluvialis algal biomass by Supercritical CO2 extraction technology. It is a dark 
red viscous oleoresin, for use in Nutraceutical, Cosmetics and Food products. 
 
Atacama Bio Natural Products S.A. (http://www.atacamabionatural.com/) 
 
Company Overview 
Atacama Bio Natural Products S.A. is a private, Chilean, biotechnology corporation that cultures 
algae to extract healthy ingredients for human well-being. They are industrial producers of 
natural astaxanthin from their cultures of Haematococcus pluvialis microalgae and they can 
supply their company with industrial volumes on a permanent and regular basis. They are 
interested in developing long-term business relationships with their clients for mutual benefits. 
The value of Atacama: “Just few places in the world provide the ideal conditions for low cost 
production of natural Astaxanthin from H. pluvialis microalgae”. 
A 250 acres facility in a high light intensity region with pure water from the Andes mountains 
makes Atacama Bio a prime producer that can greatly expand its production capacity to meet 
demand. Company initiates the year 2003 and after a long work of research has developed a 
robust, state-of-the-art, proprietary culture technology of closed and open photobioreactors. 
Their Process 
Pure water from the Andes Mountain range, after a careful process to ensure sterilization is 
used for the preparation of the growing media. NonGenetically Modified microalgae is 
inoculated in the aseptic culture medium of the photobioreactors. 
As microorganism contamination is the principal risk in this industry, they use for culture growth 
different types of enclosed photobioreactors that are kept very clean. They use HEPA filtered 
air and reverse osmosis and ozone treated water as well as food grade nutrients. 
The last stage of production is done in open pond photobioreactors where Haematococcus 
pluvialis grows in a way that resembles their natural environment. Harvested microalgae is 
ground and vacuum dried at low temperature, preserving the original characteristics and 
obtaining a powder of very high bioavailability that is mixed with vegetable oil. 
Product and End-User/ Application 
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Their prime product is natural, 3S, 3’S Astaxanthin stereoisomer from Haematococcus pluvialis, 
NAXA verified Astaxanthin. It has several uses for human consumption and animal feed 
purposes. Their main products are oleoresin extracted by supercritical CO2 and dried 
microalgae biomass. 
Food Grade 
Oleoresin 
Extracted from the milled and dried biomass of H. pluvialis by means of CO2 supercritical 
extraction process. For applications in food, beverage, dietary supplements and cosmetics 
products, it is supplied in 5% and 10% standardized content of Astaxanthin complex.  
Beadlets 
Free flowing powder, 2% and 2,5% standardized content of Astaxanthin complex for 
applications in tablets and hard capsules. 
Feed Grade 
As a natural ingredient to manufacture feed for fish, crustaceans and hens.  
They also are experienced culturing sp. Spirulina and Dunaliella salina. 
 
Heliae Development LLC (https://heliaeglobal.com/news/) 
Company Overview 
Heliae is an applied life sciences and technology company. A critical component of Heliae’s 
core mission is to create sustainable products and solutions that enhance soil, plant, animal, 
and human health. Their focus is on researching and developing microalgae and other cutting-
edge biological platforms for commercial scale production of useful products. Heliae both seeks 
and welcomes opportunities to collaborate with industry and research groups. 
Their partnerships range for the development and operation of new microalgae production 
facilities, such as their Alvita joint venture with Sincere Corporation of Japan. 
In 2008, Heliae was founded on the premise that algae can provide significant value to society 
if commercialized with the appropriate technology. This long view has allowed Heliae to build a 
base of technology that provides a distinct competitive advantage in the industry and has 
positioned the company as the leader in providing algae technology solutions to the industry 
and algae products to consumers. 
The collaboration began in late 2014 when Heliae partnered with Sincere Corporation to design 
a microalgae production facility to produce natural astaxanthin, from microalgae for the 
Japanese market. Heliae provided the technological and biological expertise along with project 
management leadership in launching Alvita. 
Method of cultivation of microalgae 
Heliae has experience in commercial scale production of products from a variety of biological 
platforms using novel and conventional phototrophic, mixotrophic and heterotrophic growth 
systems. Heliae currently employs all three at its research and demonstration production 
facilities located near Phoenix, Arizona, USA. 
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The location of the Saga City facility, near the incineration plant, offers Alvita the opportunity to 
recycle CO2 and use low grade waste heat for optimal temperature control of the reactors. 
Heliae and Alvita utilize a fully enclosed phototrophic raceway production system seeded by a 
proprietary seed growth system. This harmonization of technology and infrastructure allows 
natural sunlight to induce astaxanthin production without exposure to contamination found with 
other approaches to microalgae production. This approach mimics nature while protecting 
product quality and purity. 
The test facility consists of six open pond reactors housed inside a locally built greenhouse. 
Along with the reactors, a fully functioning laboratory was shipped for analysis of culture growth 
parameters. As of early May 2015, they have carried out seven successful production runs in 
the test reactors with their Japanese partners. 
Product and End-User/ Application 
Heliae is constantly developing new commercial products for distribution in a variety of fields. 
Currently they sell a high quality astaxanthin ingredient and PhycoTerra®, an agricultural 
product that has demonstrated promising efficacy in initial field trials. Heliae supplies its human 
supplement grade astaxanthin to leading retail outlets through a preferred supply agreement 
with a commercial supplement formulation partner. With ongoing and regular increases in 
production, Heliae can supply the same high quality astaxanthin to other customers for 
applications including animal nutrition, aquaculture, and cosmetics. They also engage in 
contract research and manufacture; collaborative research; and licensing. 
Algatechnologies Ltd. (https://www.algatech.com/) 
Company Overview 
Algatechnologies is a rapidly growing biotechnology company, specializing in the commercial 
cultivation of microalgae. Founded in 1998, Algatech is a world leader in the production and 
supply of AstaPure®, a premium natural astaxanthin - one of the world’s most powerful 
antioxidants sourced from the microalga Haematococcus pluvialis.  
Located in Israel's Arava desert – with its stable climate and high light intensity – 
Algatechnologies is ideally positioned to cultivate algae. The company produces astaxanthin in 
an innovative process, and markets its AstaPure® brand to the nutrition, food & beverages and 
cosmetics industries.  
Algatechnologies enjoys a global presence through a well-established marketing network of 
selected distributors and agents. The company's sales organization serves more than 30 
countries, via an extensive network of exclusive distributors and by direct sales to multi-national 
customers. The company provides logistics, warehousing and lab support services, offering 
customers reliable supply and prompt response.  
Algatechnologies' objectives are: 1. To provide the highest quality of natural astaxanthin, 
backed by experienced technical and marketing support. 2. To continue developing, producing 
and commercializing advanced algal-based products to the fastest growing markets by utilizing 
proprietary algal cultivation and processing technologies. 
Product and End-User/ Application 
AstaPure® astaxanthin is derived from a microalga called Haematococcus pluvialis. 
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Beijing Ginko Group (BGG) Biological Technology Co. Ltd. (https://bggworld.com/) 
 
Company Overview 
BGG is a global leader in the development and purification of high quality active natural plant 
ingredients for the dietary supplement, pharmaceutical, personal care, and food and beverage 
industries. Founded in 1995, BGG employs a staff of approximately 400, has 6 production sites, 
international branches in North America, Japan, China and Switzerland and manages sales in 
more than 70 countries. BGG selects raw materials, which are primarily from wild-crafted, 
organic, and from non-GMO sources, whenever possible. From these they produce health 
products and nutritional solutions that aid and enhance people's well-being and quality of life. 
BGG is a leader in Astaxanthin production and technology worldwide. BGG has aimed to impart 
the absolute highest quality algae-based ingredients at an appreciative price. It features 
products which are unmatched in terms of purity, potency and overall quality. Their product 
range of BGG is consisted of the world’s first Certified Organic Haematococcus pluvialis 
microalgae powder. The company has been predicted to be the world’s largest producer of 
Natural Astaxanthin by the year 2020. Nutraceutical ingredients from algae are promptly 
evolving into an important segment of the supplement industry (Industry Arc, 2018). 
For instance, the year 2014 witnessed China-based Beijing Gingko Group Biotechnology Co 
Ltd (BGG) inaugurating a 150-acre Haematococcus pluvialis production base in Shilin County, 
making the facility the largest in Asia-Pacific, with an annual H. pluvialis algae freeze-dried 
powder production capacity of 100 tons. The company has also disclosed intentions for further 
increasing this capacity to 300 tons per year over the coming years. 
Product and End-User/ Application 
They supply dry biomass (powder) of Haematococcus pluvialis with different astaxanthin 
content in bulk, which can be used for food and feed as well as further refinement. Key products 
include: AstaZine®, Natural Astaxanthin from Haemattococus Pluvialis algae farmed in world’s 
First Organically Certified Astaxanthin Farm. 
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AstaZine® is a line of natural astaxanthin products from Haematococcus pluvialis microalgae 
produced in a fully-closed, 100%-glass tube eco-friendly photobioreactor system. 
AstaZine®: 
• Contains 97% pure astaxanthin in the carotenoid fraction and just 3% of other carotenoids 
• Organically Certified astaxanthin product (certified by Ecocert®) 
• Covered by two NDIs with US FDA at 12mg and 24mg per day 
• Supported with 239 health claims submitted to US FDA without objection 
• Astaxanthin with two European Novel Foods approvals for both supercritical CO2 and ethanol 
extracts. 
• Self-affirmed GRAS 
• Registered for sale in most of the world’s most regulated markets 
 
Algae Health Sciences, Inc., a subsidiary of BGG, focuses on the production and marketing 
of efficacious ingredients from natural algae sources. Algae Health Science’s flagship product, 
AstaZine® Natural Astaxanthin, is extracted from the world’s first Certified Organic 
Haematococcus pluvialis microalgae. 
Algae Health Sciences, Inc., is a proud member of NAXA, the Natural Algae Astaxanthin 
Association. Algae Health Sciences and BGG support the NAXA Verification Program (NAVP) 
to address the growing problem of adulteration within the dietary supplement industry and 
assure finished product manufacturers and consumers that the astaxanthin they are purchasing 
is natural astaxanthin derived from Haematococcus pluvialis. 
Method of cultivation of microalgae 
Their Certified Organic Haematococcus Pluvialis microalgae powder and other fine Astaxanthin 
products are the result of years of dedicated research and a huge investment in the world’s 
premier Natural Astaxanthin facility. AstaZine® is produced through cultivation of the 
microalgae Haematococcus pluvialis in high technology 100% glass-tube photobioreactors. 
AstaZine® is cultivated using clean water from the Himalaya Mountains which still undergoes 
reverse osmosis before being used to grow our microalgae cultures; this ensures maximum 
purity and safety. Algae Health’s team of scientists and algae production experts has toiled for 
years to attain the utmost level of technical abilities in the microalgae field.  
 
Yunnan Alphy Biotech Co., Ltd. 
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Company Overview 
Yunnan Alphy Biotech Co.,Ltd. is a high-technology company engaged in engineering large-
cell culture of Haematococcus pluvialis for the production of natural astaxanthin. The company 
was founded May 10, 2007, with registered capital of ten million yuan. The registered business 
scopes include; Biotechnology research and development and technology transfer, 
Aquaculture of aquatic organisms, and production and marketing of related products. 
Product and End-User/ Application 
They specialize in the production of natural astaxanthin from green microalgae, 
Heamatococcus pluvialis and extraction of astaxanthin oleoresin via supercritical CO2.  
Products 
• Heamatococcus pluvialis biomass/ H.p powder  
• Astaxanthin oil/ astaxanthin olereosin 
• Astaxanthin CWS powder 
• OEM&ODM 
 
Fuji Chemical Industry Co. Ltd. (AstaReal Co Tld) (http://www.fujichemical.co.jp/english/) 
Company Overview 
The Fuji Chemical Industries Group began its work with astaxanthin, renowned for its benefits 
in the prevention of disease, as early as 1994. Since then, they have diversified their 
astaxanthin business from raw materials to the marketing of finished products. They have also 
been actively involved in seminars and symposiums on astaxanthin and have accumulated a 
wealth of research evidence in collaboration with universities and research organizations. The 
Fuji Chemical Industries Group will continue in its role as a leading innovator of astaxanthin in 
order to make a positive contribution to the evolution of preventive health care.  
They currently market their astaxanthin-based AstaREAL® ACT dietary supplement and 
ASTARISM® skincare base beauty essence to more than 1200 health care facilities all over 
Japan and are expanding our efforts with the aid of experts in disease prevention & medicine. 
Product and End-User/ Application 
AstaReal are pioneers in microalgae cultivation. In the early 1990s, we developed a highly 
advanced and one-of-a-kind technology using specially designed photobioreactors to cultivate 
the microalgae Haematococcus pluvialis (HP). 
Their first indoor production facility was established in Gustavsberg, Sweden, where we 
became the first company in the world to commercially produce natural astaxanthin from 
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microalgae in the early 1990s. The facility is ISO, HACCP certified, and our production is both 
Halal and Kosher certified. 
Their commitment to ensuring the supply of superior natural astaxanthin products is further 
underpinned by the opening of a new manufacturing facility in 2014. Their newest facility is in 
Moses Lake Washington, USA, and uses the same innovative photobioreactor system 
developed in Sweden. As a result, the AstaReal Group´s production capacity has tripled, 
allowing them to consistently meet the ever-increasing global demand for superior, natural 
astaxanthin. 
The AstaReal Group together with their parent company Fuji Chemical Industries Co., Ltd. are 
world leaders in research based natural astaxanthin health products. The Group continues to 
lead the way in the production and innovation of natural astaxanthin. 
AstaReal astaxanthin is offered in a variety of bulk forms to suit your final product. 
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